https://clinicalinfo.hiv.gov/endaily1.0 https://clinicalinfo.hiv.gov/en/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/fda-label2026-03-18T23:43Zyearly https://clinicalinfo.hiv.gov/en/page-4042020-09-15T07:44Znever https://clinicalinfo.hiv.gov/en/guidelines-archive2022-06-08T14:43Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adverse-effects-antiretroviral-medications-full2026-05-27T14:25Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-nrti-full2026-05-27T14:27Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-c-virus-hiv-full2026-05-27T14:28Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-pi-full2026-05-27T14:27Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/treatment-hiv-associated-full2026-02-25T14:30Zyearly https://clinicalinfo.hiv.gov/en/table/potential-clinically-relevant-interactions-between-antimalarial-and-antiretroviral-drugs2025-09-18T22:41Zyearly https://clinicalinfo.hiv.gov/en/table/dosing-recommendations-prevention-and-treatment-malaria2024-11-21T15:54Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table/table-1-primary-prophylaxis-full2026-04-23T18:26Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-2-secondary-prophylaxis-full2026-04-23T18:31Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-3-treatment-full2026-04-23T18:35Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table/table-4-common-drugs-used-treatment-opportunistic-infections-hiv-infected-children2025-09-18T23:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/antepartum-care-initial-evaluation-monitoring-hiv-assessments-during-pregnancy-full2025-06-12T17:54Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-drug-use-pregnant-full2026-04-23T12:59Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/review-clinical-trials-arv-interventions-prevent-hiv-transmission-full2024-01-26T14:48Znever https://clinicalinfo.hiv.gov/en/table/appendix-c-clinical-trial-efficacy-data-daily-oral-tenofovir-disoproxil-fumarateemtricitabine2020-12-29T15:41Znever https://clinicalinfo.hiv.gov/en/table/raltegravir2020-11-27T21:50Znever https://clinicalinfo.hiv.gov/en/table/table-summary-impaact-p1066-cohorts-and-participation2020-11-19T16:46Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/raltegravir-full2022-04-11T15:15Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/cns-toxicity-full2025-11-17T21:08Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/dyslipidemia-full2025-09-30T14:59Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/gastrointestinal-effects-full2024-07-01T15:09Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/hematologic-effects-full2025-09-30T15:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/hepatic-events-full2025-09-30T15:47Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/insulin-resistance-asymptomatic-hyperglycemia-diabetes-mellitus-full2025-09-30T15:50Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lactic-acidosis-full2025-09-30T15:53Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lipodystrophies-and-weight-gain-full2025-09-30T15:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/nephrotoxic-effects-full2024-07-01T16:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/osteopenia-and-osteoporosis-full2025-09-30T16:02Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/rash-and-hypersensitivity-reactions-full2025-09-30T16:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/appendix-table-1-antiretrovirals-available-fixed-dose-combination-tablets-full2025-09-30T18:37Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-fostemsavir-rukobia2026-03-31T16:37Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-situation-specific-conceive-full2026-03-31T14:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/pre-exposure-prophylaxis-prep-prevent-hiv2026-04-01T15:53Zyearly https://clinicalinfo.hiv.gov/en/node/111762024-06-12T19:29Zyearly https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-1/patient2026-01-28T21:07Zyearly https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-1/fda-label2024-06-15T03:35Zyearly https://clinicalinfo.hiv.gov/en/node/111792024-06-12T19:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-rilpivirine/patient2026-01-30T19:38Zyearly https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-rilpivirine/fda-label2024-06-15T03:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/fostemsavir2025-12-03T17:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/cabotegravir2025-12-03T17:29Zyearly https://clinicalinfo.hiv.gov/en/node/111932023-05-03T19:14Znever https://clinicalinfo.hiv.gov/en/drugs/tenofovir-alafenamide/patient2026-02-20T02:49Zyearly https://clinicalinfo.hiv.gov/en/drugs/tenofovir-alafenamide/fda-label2024-06-22T01:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-combination-regimens2025-12-02T17:03Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-protease-inhibitor-based-regimens2025-12-02T17:07Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-advantages-disadvantages2025-12-02T17:11Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-other-antiretroviral-regimens2026-02-05T22:39Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-antiretroviral-specific-clinical-scenarios2025-12-02T17:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-non-nucleoside-reverse-transcriptase-inhibitor2025-12-02T17:06Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-integrase-strand-transfer-inhibitor2025-12-08T19:52Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-nucleoside-reverse-transcriptase-inhibitor2025-12-02T17:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-hiv-1-gp120-inhibitors2025-12-01T23:42Zyearly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/all-archived-guidelines2025-05-12T18:48Zyearly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/adult-and-adolescent-guidelines2026-05-27T15:40Zweekly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/adult-oi-guidelines2026-04-28T16:34Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/pediatric-guidelines2026-04-22T14:52Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/pediatric-oi-guidelines2026-04-28T16:58Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/perinatal-guidelines2026-04-22T21:12Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/guidance-hiv-disasters2026-02-20T14:07Zyearly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines/guidance-covid-19-and-people-hiv-archive2025-12-29T17:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/archived-guidelines2025-12-29T17:34Zyearly https://clinicalinfo.hiv.gov/en/drugs/10-1074/patient2026-02-21T00:55Zyearly https://clinicalinfo.hiv.gov/en/node/112422026-01-26T20:12Zyearly https://clinicalinfo.hiv.gov/en/drugs/10-1074/health-professional2026-01-26T20:12Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/special-populations2026-02-27T20:09Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/special-populations-early-recent-acute-hiv-infection2026-03-31T14:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/special-populations-prenatal-care-art-hiv-management-acquired-infection2026-04-22T14:07Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/special-populations-hepatitis-b-virus-hiv-coinfection2026-04-02T18:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/special-populations-hepatitis-c-virus-hiv-coinfection2026-03-31T14:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/special-populations-hiv-2-infection-pregnancy2026-03-31T14:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-cabotegravir-vocabria2026-04-01T19:25Zyearly https://clinicalinfo.hiv.gov/en/news/living-hiv2024-12-04T20:22Zyearly https://clinicalinfo.hiv.gov/en/news/hiv-and-special-populations2024-04-30T19:24Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-12022-12-06T18:52Znever https://clinicalinfo.hiv.gov/en/news/nominations-new-members-join-hhs-panel-prevention-and-treatment-opportunistic-infections-hiv2024-04-30T19:04Znever https://clinicalinfo.hiv.gov/en/news/hiv-and-opportunistic-infections-coinfections-and-conditions2024-12-04T20:31Zyearly https://clinicalinfo.hiv.gov/en/news/community-member-nominations-are-now-being-accepted-department-health-and-human-services-hhs2024-04-30T18:47Znever https://clinicalinfo.hiv.gov/en/news/scientificclinical-member-nominations-are-now-being-accepted-department-health-and-human2022-12-06T18:34Znever https://clinicalinfo.hiv.gov/en/news/national-black-hivaids-awareness-day2024-04-30T18:37Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-12022-12-06T18:49Znever https://clinicalinfo.hiv.gov/en/news/whats-new-covid-19-and-hiv-guidance2024-04-30T19:08Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/appendix-c-cdc-pediatric-hiv-cd4-cell2025-11-25T20:48Zyearly https://clinicalinfo.hiv.gov/en/news/national-native-hivaids-awareness-day-02024-04-25T21:53Znever https://clinicalinfo.hiv.gov/en/news/national-lgbtq-health-awareness-week2024-05-28T18:50Znever https://clinicalinfo.hiv.gov/en/glossary/primary-effusion-lymphoma-pel2024-02-05T19:23Znever https://clinicalinfo.hiv.gov/en/glossary/analytical-treatment-interruption-ati2024-08-06T19:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/acute-retinal-necrosis-arn2024-06-28T21:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/toxoplasma-gondii-encephalitis2024-02-12T14:11Znever https://clinicalinfo.hiv.gov/en/glossary/antacids2024-02-01T18:37Znever https://clinicalinfo.hiv.gov/en/glossary/intravaginal-ring-ivr2024-07-03T02:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/community-acquired-pneumonia-cap2024-08-13T03:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/hepatitis-virus-infection-hav2024-07-03T01:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/primary-varicella-infection2024-02-01T18:42Znever https://clinicalinfo.hiv.gov/en/glossary/capsid-inhibitors2024-02-01T19:46Znever https://clinicalinfo.hiv.gov/en/glossary/maturation-inhibitor-mi2024-10-25T03:10Zyearly https://clinicalinfo.hiv.gov/en/glossary/clinical-hold2024-07-02T02:23Zyearly https://clinicalinfo.hiv.gov/en/news/updated-hhs-pediatric-antiretroviral-therapy-guidelines-released-02022-12-06T18:30Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-22022-12-06T18:31Znever https://clinicalinfo.hiv.gov/en/news/national-transgender-hiv-testing-day-resources2024-05-28T18:53Znever https://clinicalinfo.hiv.gov/en/news/hivinfo-releases-new-hiv-and-covid-19-fact-sheet2023-05-05T20:42Znever https://clinicalinfo.hiv.gov/en/news/updated-resources-available-fda-approved-hiv-medicines2024-12-04T19:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/multicentric-castleman-disease-mcd2024-07-03T21:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/progressive-outer-retinal-necrosis-porn2024-02-01T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/vulvovaginal-candidiasis2024-02-01T18:41Znever https://clinicalinfo.hiv.gov/en/glossary/sulfa-medicines2024-07-06T03:29Zyearly https://clinicalinfo.hiv.gov/en/glossary/empiric-therapy2024-07-02T03:05Zyearly https://clinicalinfo.hiv.gov/en/glossary/herpes-simplex-virus-hsv2024-07-03T01:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/functional-monotherapy2024-02-01T20:37Znever https://clinicalinfo.hiv.gov/en/glossary/multidrug-resistant-hiv-mdr-hiv2024-07-29T17:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/phenylketonuria2024-02-13T03:04Znever https://clinicalinfo.hiv.gov/en/glossary/implant2024-02-08T21:48Znever https://clinicalinfo.hiv.gov/en/glossary/dosage-form2024-02-15T19:54Znever https://clinicalinfo.hiv.gov/en/glossary/pol2023-01-10T07:46Znever https://clinicalinfo.hiv.gov/en/glossary/multipurpose-prevention-technology-mpt2024-02-13T02:05Znever https://clinicalinfo.hiv.gov/en/glossary/gag2024-02-01T21:43Znever https://clinicalinfo.hiv.gov/en/glossary/env2024-02-01T21:18Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/study-and-trial-names2025-12-03T17:41Zyearly https://clinicalinfo.hiv.gov/en/news/hivinfo-has-new-email-address-hivinfonihgov2022-09-27T16:09Znever https://clinicalinfo.hiv.gov/en/news/updated-resource-available-three-things-know-about-hiv-treatment2024-04-25T19:20Znever https://clinicalinfo.hiv.gov/en/news/national-hiv-testing-day-resources2023-06-02T14:50Znever https://clinicalinfo.hiv.gov/en/glossary/drug-food-interaction2024-08-15T02:10Zyearly https://clinicalinfo.hiv.gov/en/glossary/desiccant2024-02-01T21:02Znever https://clinicalinfo.hiv.gov/en/glossary/bronchitis2024-02-01T19:11Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/mpox2026-03-25T17:51Zyearly https://clinicalinfo.hiv.gov/en/news/hiv-and-pregnancy-resources-available2023-05-08T14:58Znever https://clinicalinfo.hiv.gov/en/news/updated-contact-information-hivinfo2023-05-05T20:34Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-32024-12-04T20:21Zyearly https://clinicalinfo.hiv.gov/en/news/explore-hiv-and-immunization-resources-national-immunization-awareness-month2024-04-30T18:35Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-22023-05-05T21:28Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-hiv-exposed2023-08-02T16:45Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-42024-04-25T21:34Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables2026-05-27T14:26Zweekly https://clinicalinfo.hiv.gov/en/node/117012023-09-20T01:10Znever https://clinicalinfo.hiv.gov/en/drugs/smallpox-and-mpox-vaccine/fda-label2025-01-15T20:46Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-renal-hepatic-insufficiency-full2026-03-30T15:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/study-and-trial-names2026-03-30T15:18Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-nnrti-full2026-05-27T14:27Zweekly https://clinicalinfo.hiv.gov/en/drugs/smallpox-and-mpox-vaccine/patient2025-06-17T19:32Zyearly https://clinicalinfo.hiv.gov/en/news/reflections-aids-2022-global-village2023-05-05T20:27Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-32022-12-06T17:26Znever https://clinicalinfo.hiv.gov/en/news/national-gay-mens-hivaids-awareness-day-resources2024-05-28T18:51Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-52024-04-25T21:59Znever https://clinicalinfo.hiv.gov/en/node/117562023-09-20T01:09Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-pediatric-hiv-infection2023-10-05T19:45Znever https://clinicalinfo.hiv.gov/en/news/national-latinx-aids-awareness-day-resources-02024-05-28T19:30Znever https://clinicalinfo.hiv.gov/en/drugs/vorinostat/health-professional2026-01-13T23:24Zyearly https://clinicalinfo.hiv.gov/en/node/117862024-11-07T17:41Zyearly https://clinicalinfo.hiv.gov/en/drugs/tecovirimat/patient2026-02-20T23:59Zyearly https://clinicalinfo.hiv.gov/en/news/scientificclinical-member-nominations-are-now-being-accepted-department-health-and-human-02023-10-05T19:45Znever https://clinicalinfo.hiv.gov/en/drugs/tecovirimat/health-professional2024-11-08T03:25Zyearly https://clinicalinfo.hiv.gov/en/drugs/rifampin/fda-label2024-06-22T01:21Zyearly https://clinicalinfo.hiv.gov/en/news/nih-world-aids-day-20222023-10-05T19:46Znever https://clinicalinfo.hiv.gov/en/news/save-date-nih-world-aids-day-2022-virtual-event2023-11-13T13:27Znever https://clinicalinfo.hiv.gov/en/news/clinicalinfo-website-now-optimized-mobile-browsing-app-sunset-december-302023-11-21T20:12Znever https://clinicalinfo.hiv.gov/en/node/118262023-01-23T17:38Znever https://clinicalinfo.hiv.gov/en/drugs/fidaxomicin/patient2025-03-28T22:08Zyearly https://clinicalinfo.hiv.gov/en/drugs/fidaxomicin/fda-label2024-06-21T01:49Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-62023-05-05T16:35Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/recommendations-use-arv-drugs-during-pregnancy2023-01-30T22:54Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-hiv-conceive2026-03-31T20:49Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-prevent-hiv-transmission-improve-health2026-01-05T15:00Zyearly https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications2024-12-02T21:57Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/antepartum-care2026-03-31T14:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-overview2026-04-02T18:27Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-initial-use-antiretroviral-therapy2026-03-31T15:50Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-art-taken-when-pregnancy-occurs2026-03-31T15:52Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-previous-experience-not-on-art-during-current2026-03-31T14:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-lack-viral-suppression-on-antiretroviral-therapy2026-03-31T14:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-what-start-art-never-received2026-03-31T14:23Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-situation-specific-conceive2026-03-31T14:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-teratogenicity2026-03-31T14:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/recommendations-arv-drugs-pregnancy-regimens-maternal-neonatal-outcomes2026-01-05T14:58Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/preventing-transmission-infant-feeding2025-07-23T17:27Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/appendix-a-drug-name-abbreviations2026-03-31T15:54Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/appendix-a-acronyms-general-terms2026-03-31T16:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/appendix-a-study-trials-names2026-03-31T15:59Zyearly https://clinicalinfo.hiv.gov/en/news/recommendations-use-arv-drugs-during-pregnancy-interventions-reduce-perinatal-hiv-transmission2024-12-04T20:26Zyearly https://clinicalinfo.hiv.gov/en/node/119462023-02-22T21:39Znever https://clinicalinfo.hiv.gov/en/drugs/gentamicin/patient2025-04-16T15:34Zyearly https://clinicalinfo.hiv.gov/en/drugs/gentamicin/fda-label2025-12-05T01:07Zyearly https://clinicalinfo.hiv.gov/en/node/119612025-06-27T19:26Zyearly https://clinicalinfo.hiv.gov/en/drugs/lenacapavir/patient2026-02-19T02:16Zyearly https://clinicalinfo.hiv.gov/en/drugs/lenacapavir/fda-label2025-06-27T19:25Zyearly https://clinicalinfo.hiv.gov/en/node/119762025-05-20T23:44Zyearly https://clinicalinfo.hiv.gov/en/drugs/doxycycline/patient2025-05-20T23:46Zyearly https://clinicalinfo.hiv.gov/en/node/119912026-02-18T03:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/erythromycin/fda-label2026-02-18T03:05Zyearly https://clinicalinfo.hiv.gov/en/drugs/erythromycin/patient2026-02-18T03:03Zyearly https://clinicalinfo.hiv.gov/en/node/120212024-06-12T19:28Zyearly https://clinicalinfo.hiv.gov/en/node/120262024-06-12T19:29Zyearly https://clinicalinfo.hiv.gov/en/node/120312025-06-27T19:26Zyearly https://clinicalinfo.hiv.gov/en/node/120362025-08-13T23:53Zyearly https://clinicalinfo.hiv.gov/en/drugs/pneumococcal-conjugate-vaccines/patient2026-02-20T00:29Zyearly https://clinicalinfo.hiv.gov/en/drugs/pneumococcal-conjugate-vaccines/fda-label2025-08-13T23:57Zyearly https://clinicalinfo.hiv.gov/en/drugs/doxcycline/fda-label2025-05-20T23:47Zyearly https://clinicalinfo.hiv.gov/en/node/120662023-02-28T19:26Znever https://clinicalinfo.hiv.gov/en/drugs/nifurtimox/patient2025-04-16T15:36Zyearly https://clinicalinfo.hiv.gov/en/drugs/nifurtimox/fda-label2024-06-21T02:57Zyearly https://clinicalinfo.hiv.gov/en/node/120962023-03-08T23:16Znever https://clinicalinfo.hiv.gov/en/node/121012025-08-13T23:54Zyearly https://clinicalinfo.hiv.gov/en/node/121062025-08-13T23:55Zyearly https://clinicalinfo.hiv.gov/en/node/121112024-06-13T02:44Zyearly https://clinicalinfo.hiv.gov/en/node/121162024-06-13T02:44Zyearly https://clinicalinfo.hiv.gov/en/node/121212024-06-13T02:45Zyearly https://clinicalinfo.hiv.gov/en/node/121312025-01-13T20:12Zyearly https://clinicalinfo.hiv.gov/en/node/121362025-01-13T20:13Zyearly https://clinicalinfo.hiv.gov/en/drugs/pneumococcal-vaccine-polyvalent/patient2026-02-20T23:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/pneumococcal-vaccine-polyvalent/fda-label2025-01-15T20:51Zyearly https://clinicalinfo.hiv.gov/en/node/121512023-03-14T23:42Znever https://clinicalinfo.hiv.gov/en/drugs/benznidazole/patient2025-04-16T15:44Zyearly https://clinicalinfo.hiv.gov/en/drugs/benznidazole/fda-label2024-06-21T01:14Zyearly https://clinicalinfo.hiv.gov/en/news/national-women-and-girls-hivaids-awareness-day-02024-05-28T18:56Znever https://clinicalinfo.hiv.gov/en/news/nih-symposium-launches-oar-orwh-partnership-advance-research-hiv-and-women2023-05-05T16:40Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-capsid-inhibitor2025-12-01T23:41Zyearly https://clinicalinfo.hiv.gov/en/news/national-native-hivaids-awareness-day-12024-04-30T18:36Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-02024-12-02T21:51Zyearly https://clinicalinfo.hiv.gov/en/node/122062025-01-13T20:17Zyearly https://clinicalinfo.hiv.gov/en/drugs/influenza-virus-vaccines-inactivated-or-recombinant/patient2025-03-28T22:06Zyearly https://clinicalinfo.hiv.gov/en/drugs/influenza-virus-vaccines-inactivated-or-recombinant/fda-label2025-01-11T01:13Zyearly https://clinicalinfo.hiv.gov/en/news/national-youth-hiv-aids-awareness-day2023-05-05T20:48Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-02023-05-05T20:55Znever https://clinicalinfo.hiv.gov/en/node/122712025-01-13T20:25Zyearly https://clinicalinfo.hiv.gov/en/node/122762025-01-13T20:20Zyearly https://clinicalinfo.hiv.gov/en/node/122812025-01-13T20:24Zyearly https://clinicalinfo.hiv.gov/en/node/122962025-01-13T20:19Zyearly https://clinicalinfo.hiv.gov/en/node/123012025-01-13T20:23Zyearly https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-announces-new-scientific-members2023-05-02T21:17Znever https://clinicalinfo.hiv.gov/en/node/123212025-05-09T02:24Zyearly https://clinicalinfo.hiv.gov/en/drugs/amoxicillin-clavulanate-potassium/patient2026-02-20T00:14Zyearly https://clinicalinfo.hiv.gov/en/drugs/amoxicillin-clavulanate-potassium/fda-label2025-05-09T02:23Zyearly https://clinicalinfo.hiv.gov/en/node/123462023-05-09T01:07Znever https://clinicalinfo.hiv.gov/en/node/123512025-01-13T20:16Zyearly https://clinicalinfo.hiv.gov/en/drugs/amoxicillin/patient2026-02-19T23:52Zyearly https://clinicalinfo.hiv.gov/en/drugs/amoxicillin/fda-label2024-06-20T02:50Zyearly https://clinicalinfo.hiv.gov/en/news/hiv-vaccine-awareness-day2023-05-19T13:55Znever https://clinicalinfo.hiv.gov/en/node/123712023-05-26T21:13Znever https://clinicalinfo.hiv.gov/en/drugs/entecavir/patient2026-02-20T23:07Zyearly https://clinicalinfo.hiv.gov/en/drugs/entecavir/fda-label2024-06-21T01:39Zyearly https://clinicalinfo.hiv.gov/en/node/123862023-06-07T19:28Znever https://clinicalinfo.hiv.gov/en/drugs/doxorubicin-hydrochloride-liposomal/patient2026-02-19T03:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/doxorubicin-hydrochloride-liposomal/fda-label2024-06-21T01:31Zyearly https://clinicalinfo.hiv.gov/en/node/124062023-06-16T20:47Znever https://clinicalinfo.hiv.gov/en/drugs/rituximab/patient2026-02-19T02:33Zyearly https://clinicalinfo.hiv.gov/en/drugs/rituximab/fda-label2024-06-22T01:23Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-72024-04-30T19:16Znever https://clinicalinfo.hiv.gov/en/node/124262024-12-26T22:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/podofilox/patient2026-02-20T22:51Zyearly https://clinicalinfo.hiv.gov/en/drugs/podofilox/fda-label2024-12-26T22:24Zyearly https://clinicalinfo.hiv.gov/en/news/national-hiv-testing-day2024-11-26T20:36Zyearly https://clinicalinfo.hiv.gov/en/node/124512023-07-11T02:55Znever https://clinicalinfo.hiv.gov/en/drugs/rifapentine/patient2026-02-20T00:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/rifapentine/fda-label2024-06-22T01:22Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-82023-07-25T13:19Znever https://clinicalinfo.hiv.gov/en/node/124762023-07-26T00:48Znever https://clinicalinfo.hiv.gov/en/node/124812025-07-10T19:24Zyearly https://clinicalinfo.hiv.gov/en/drugs/penicillin-g-benzathine/patient2026-02-20T23:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/penicillin-g-benzathine/fda-label2024-06-21T03:03Zyearly https://clinicalinfo.hiv.gov/en/node/124962025-07-08T19:50Zyearly https://clinicalinfo.hiv.gov/en/drugs/vh3810109/health-professional2025-07-10T14:24Zyearly https://clinicalinfo.hiv.gov/en/drugs/vh3810109/patient2026-02-20T02:35Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv2023-11-02T20:08Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-92023-09-07T21:11Znever https://clinicalinfo.hiv.gov/en/glossary/mpox2024-10-25T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/mpox-virus2024-07-03T21:48Zyearly https://clinicalinfo.hiv.gov/en/node/125362024-06-13T18:46Zyearly https://clinicalinfo.hiv.gov/en/drugs/penicillin-g-potassium-or-sodium/patient2026-02-19T23:58Zyearly https://clinicalinfo.hiv.gov/en/drugs/penicillin-g-potassium-or-sodium/fda-label2024-06-21T03:01Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-02023-09-14T18:02Znever https://clinicalinfo.hiv.gov/en/node/125612024-09-12T01:43Zyearly https://clinicalinfo.hiv.gov/en/drugs/vrc07-523ls/health-professional2026-03-25T20:18Zyearly https://clinicalinfo.hiv.gov/en/drugs/vrc07-523ls/patient2026-03-25T20:18Zyearly https://clinicalinfo.hiv.gov/en/news/perinatal-hiv-transmission-updated-fact-sheets-available2024-12-04T20:13Zyearly https://clinicalinfo.hiv.gov/en/node/125812025-08-20T19:51Zyearly https://clinicalinfo.hiv.gov/en/drugs/dapsone-oral/patient2025-08-20T19:50Zyearly https://clinicalinfo.hiv.gov/en/drugs/dapsone-oral/fda-label2025-08-20T19:52Zyearly https://clinicalinfo.hiv.gov/en/news/national-hivaids-and-aging-awareness-day2024-12-02T21:48Zyearly https://clinicalinfo.hiv.gov/en/node/126012023-09-19T02:27Znever https://clinicalinfo.hiv.gov/en/drugs/atovaquone/patient2026-02-20T02:41Zyearly https://clinicalinfo.hiv.gov/en/drugs/atovaquone/fda-label2024-06-21T01:08Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-102024-05-08T18:03Znever https://clinicalinfo.hiv.gov/en/node/126262023-09-22T01:03Znever https://clinicalinfo.hiv.gov/en/news/join-nih-oars-november-1-2-workshop-hiv-self-testing-and-viral-load-monitoring2023-10-05T19:48Znever https://clinicalinfo.hiv.gov/en/news/basics-hiv-and-aids-updated-fact-sheets-available2024-12-02T21:47Zyearly https://clinicalinfo.hiv.gov/en/node/126412024-06-13T18:50Zyearly https://clinicalinfo.hiv.gov/en/drugs/pentamidine-isethionate/patient2026-02-20T01:19Zyearly https://clinicalinfo.hiv.gov/en/drugs/pentamidine-isethionate/fda-label2024-06-21T03:05Zyearly https://clinicalinfo.hiv.gov/en/node/126612025-11-14T17:03Zyearly https://clinicalinfo.hiv.gov/en/drugs/cidofovir-injection/patient2026-02-19T02:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/cidofovir-injection/fda-label2024-06-21T01:22Zyearly https://clinicalinfo.hiv.gov/en/node/126762023-10-13T00:38Znever https://clinicalinfo.hiv.gov/en/drugs/brincidofovir/patient2025-11-25T16:22Zyearly https://clinicalinfo.hiv.gov/en/drugs/brincidofovir/health-professional2025-11-25T16:24Zyearly https://clinicalinfo.hiv.gov/en/node/126912023-10-12T03:05Znever https://clinicalinfo.hiv.gov/en/drugs/vaccinia-immune-globulin-human/patient2025-11-26T16:01Zyearly https://clinicalinfo.hiv.gov/en/drugs/vaccinia-immune-globulin-human/health-professional2025-11-26T16:07Zyearly https://clinicalinfo.hiv.gov/en/news/national-latinx-aids-awareness-day2023-10-16T21:42Znever https://clinicalinfo.hiv.gov/en/news/nih-world-aids-day-35-event-achieving-excellence-and-equity-hiv-research2023-11-28T14:12Znever https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-therapy-and-medical-management-children-living-hiv-accepting2024-04-30T18:46Znever https://clinicalinfo.hiv.gov/en/glossary/serodifferent-couple2024-02-01T22:13Znever https://clinicalinfo.hiv.gov/en/glossary/seroconcordant-couple2024-02-01T22:13Znever https://clinicalinfo.hiv.gov/en/news/join-us-world-aids-day2024-04-30T15:48Znever https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-42024-04-25T21:56Znever https://clinicalinfo.hiv.gov/en/node/127462024-10-18T02:25Zyearly https://clinicalinfo.hiv.gov/en/drugs/vesatolimod/health-professional2026-02-12T19:52Zyearly https://clinicalinfo.hiv.gov/en/drugs/vesatolimod/patient2026-02-12T19:52Zyearly https://clinicalinfo.hiv.gov/en/news/nominations-are-now-being-accepted-panel-guidelines-prevention-and-treatment-opportunistic2024-04-30T19:12Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-acronyms2025-12-02T19:45Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/archive-pediatric-oi2024-01-09T19:45Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/archive-human-herpesvirus-82025-12-02T19:48Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/archive-influenza2025-12-02T19:48Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/archive-progressive-multifocal2025-12-02T20:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/capsid-inhibitors2024-01-31T15:23Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-capsid-inhibitors-lenacapavir-sunlenca2026-03-31T16:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/empirical-therapy2024-07-02T03:06Zyearly https://clinicalinfo.hiv.gov/en/glossary/empirical-treatment2024-07-02T03:06Zyearly https://clinicalinfo.hiv.gov/en/glossary/vaginal-ring2024-07-03T02:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/phenylalanine-hydroxylase-deficiency2024-01-25T19:15Znever https://clinicalinfo.hiv.gov/en/glossary/chickenpox2024-01-25T19:16Znever https://clinicalinfo.hiv.gov/en/glossary/varicella2024-01-25T19:16Znever https://clinicalinfo.hiv.gov/en/glossary/varicella-zoster-virus-retinitis-vzvr2024-01-25T19:41Znever https://clinicalinfo.hiv.gov/en/glossary/sulfa-drugs2024-07-06T03:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/sulfonamides2024-07-06T03:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/toxoplasmic-encephalitis-te2024-01-25T19:19Znever https://clinicalinfo.hiv.gov/en/glossary/vaginal-candidiasis2024-01-25T19:20Znever https://clinicalinfo.hiv.gov/en/glossary/candidal-vaginitis2024-01-25T19:20Znever https://clinicalinfo.hiv.gov/en/glossary/vaginal-yeast-infection2024-01-25T19:21Znever https://clinicalinfo.hiv.gov/en/news/updates-perinatal-hiv-clinical-guidelines2024-01-31T19:31Znever https://clinicalinfo.hiv.gov/en/news/national-black-hivaids-awareness-day-02024-02-07T18:03Znever https://clinicalinfo.hiv.gov/en/news/updates-hiv-clinical-guidelines-adult-and-adolescent-arv2024-12-02T21:21Zyearly https://clinicalinfo.hiv.gov/en/news/national-women-and-girls-hivaids-awareness-day-12024-04-25T19:20Znever https://clinicalinfo.hiv.gov/en/news/national-native-hivaids-awareness-day-22024-04-25T19:15Znever https://clinicalinfo.hiv.gov/en/news/national-youth-hivaids-awareness-day2024-04-10T17:38Znever https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications-02024-04-24T20:16Znever https://clinicalinfo.hiv.gov/en/news/community-member-nominations-are-now-being-accepted-hhs-panel-antiretroviral-guidelines-02024-05-02T20:39Znever https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-hiv2024-12-04T20:32Zyearly https://clinicalinfo.hiv.gov/en/node/129562026-04-29T18:48Zmonthly https://clinicalinfo.hiv.gov/en/drugs/pgdm1400/health-professional2026-04-29T15:31Zmonthly https://clinicalinfo.hiv.gov/en/drugs/pgdm1400/patient2026-04-28T22:51Zmonthly https://clinicalinfo.hiv.gov/en/news/hiv-vaccine-awareness-day-02024-05-17T17:03Znever https://clinicalinfo.hiv.gov/en/news/hiv-long-term-survivors-awareness-day2024-06-05T18:20Znever https://clinicalinfo.hiv.gov/en/node/129812025-06-09T16:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/pgt121/health-professional2026-03-24T19:41Zyearly https://clinicalinfo.hiv.gov/en/drugs/pgt121/patient2026-03-24T19:41Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/capsid-inhibitors2024-06-25T14:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lenacapavir2025-12-03T17:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/covid-192025-09-30T20:13Zyearly https://clinicalinfo.hiv.gov/en/news/national-hiv-testing-day-02024-12-02T21:33Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection2024-06-28T16:51Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv2024-11-20T19:00Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-02024-07-09T16:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-transplantation2026-05-27T14:29Zweekly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-12024-07-30T15:33Zyearly https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-announces-new-community-and2024-07-30T17:28Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-22024-08-15T20:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/p24-02024-08-21T14:25Zyearly https://clinicalinfo.hiv.gov/en/node/131412024-08-28T01:11Zyearly https://clinicalinfo.hiv.gov/en/drugs/miltefosine/patient2025-03-28T21:55Zyearly https://clinicalinfo.hiv.gov/en/drugs/miltefosine/fda-labels2024-08-28T01:10Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-52024-12-02T21:13Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-32024-10-10T20:20Zyearly https://clinicalinfo.hiv.gov/en/news/national-hivaids-and-aging-awareness-day-02024-12-04T20:06Zyearly https://clinicalinfo.hiv.gov/en/news/national-gay-mens-hivaids-awareness-day2024-09-27T20:04Zyearly https://clinicalinfo.hiv.gov/en/node/131762024-10-08T00:42Zyearly https://clinicalinfo.hiv.gov/en/drugs/oteseconazole/patient2025-03-28T22:04Zyearly https://clinicalinfo.hiv.gov/en/drugs/oteseconazole/fda-labels2024-10-08T00:40Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-42024-10-10T20:18Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidance-people-hiv-displaced-disasters-such-hurricane2024-10-11T16:03Zyearly https://clinicalinfo.hiv.gov/en/news/national-latinx-aids-awareness-day-02024-10-15T19:28Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-112024-10-29T19:18Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-122024-11-21T15:38Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv-02024-11-21T20:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/pjp2024-11-25T02:52Zyearly https://clinicalinfo.hiv.gov/en/node/132262025-01-13T20:21Zyearly https://clinicalinfo.hiv.gov/en/node/132312025-01-13T20:22Zyearly https://clinicalinfo.hiv.gov/en/node/132362025-01-13T20:23Zyearly https://clinicalinfo.hiv.gov/en/news/register-join-nih-world-aids-day-event2024-12-02T19:02Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/tests-initial-assessment-and-follow-up-full2026-02-24T18:30Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-52024-12-19T20:19Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-02025-12-11T17:06Zyearly https://clinicalinfo.hiv.gov/en/news/update-perinatal-hiv-clinical-guidelines2024-12-19T21:43Zyearly https://clinicalinfo.hiv.gov/en/node/132712026-04-08T15:09Zyearly https://clinicalinfo.hiv.gov/en/node/132762026-04-08T15:10Zyearly https://clinicalinfo.hiv.gov/en/node/132812026-04-08T15:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/covid-19-vaccines/patient2026-04-08T15:12Zyearly https://clinicalinfo.hiv.gov/en/drugs/covid-19-vaccines/fda-labels2026-04-08T15:12Zyearly https://clinicalinfo.hiv.gov/en/news/guidance-people-hiv-displaced-los-angeles-wildfires2025-01-10T22:07Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/arv-dosing-renal-hepatic-insufficiency2025-11-21T21:36Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-62025-04-25T16:20Zyearly https://clinicalinfo.hiv.gov/en/node/133162025-06-30T22:45Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv-12025-06-10T13:02Zyearly https://clinicalinfo.hiv.gov/en/news/update-perinatal-hiv-clinical-guideline2025-06-12T20:52Zyearly https://clinicalinfo.hiv.gov/en/node/133312025-06-27T19:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/panel-roster2026-06-02T18:45Zdaily https://clinicalinfo.hiv.gov/en/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/patient2026-03-18T23:36Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/cardiovascular-and-metabolic2026-01-15T15:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/immune-activation-inflammation2026-02-06T16:09Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-72025-07-15T19:37Zyearly https://clinicalinfo.hiv.gov/en/node/133662025-08-13T23:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/cardiovascular-metabolic-complications-introduction2026-05-27T14:26Zweekly https://clinicalinfo.hiv.gov/en/node/133762026-03-26T23:56Zyearly https://clinicalinfo.hiv.gov/en/drugs/ganciclovir-ophthalmic/patient2026-03-27T17:33Zyearly https://clinicalinfo.hiv.gov/en/drugs/ganciclovir-ophthalmic/fda-labels2025-08-20T02:12Zyearly https://clinicalinfo.hiv.gov/en/node/133912026-03-26T23:52Zyearly https://clinicalinfo.hiv.gov/en/drugs/trifluridine-ophthalmic/patient2026-03-27T17:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/trifluridine-ophthalmic/fda-labels2025-08-21T17:57Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/cardiovascular-complications2026-02-24T18:11Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/weight-gain-people-treated-hiv2026-01-15T16:08Zyearly https://clinicalinfo.hiv.gov/en/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-62025-09-25T19:24Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-12025-12-11T17:06Zyearly https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications-12025-11-20T16:28Zyearly https://clinicalinfo.hiv.gov/en/news/community-member-nominations-are-now-being-accepted-hhs-panel-antiretroviral-guidelines-12025-11-20T16:29Zyearly https://clinicalinfo.hiv.gov/en/node/134362025-12-02T23:22Zyearly https://clinicalinfo.hiv.gov/en/drugs/ulonivirine/health-professional2025-12-19T18:59Zyearly https://clinicalinfo.hiv.gov/en/drugs/ulonivirine/patient2026-02-17T21:32Zyearly https://clinicalinfo.hiv.gov/en/node/134512025-12-24T18:11Zyearly https://clinicalinfo.hiv.gov/en/drugs/mk-8527/health-professional2025-12-03T02:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/mk-8527/patient2026-02-18T21:28Zyearly https://clinicalinfo.hiv.gov/en/news/update-clinical-guidelines-infant-feeding-supports-shared-decision-making-clarifying2025-12-19T21:43Zyearly https://clinicalinfo.hiv.gov/en/news/hiv-clinical-guidelines-now-recommend-high-resolution-anoscopy-part-anal-cancer-screening2025-12-19T21:43Zyearly https://clinicalinfo.hiv.gov/en/news/hhs-panel-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents2025-12-11T16:09Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv-22025-12-22T19:53Zyearly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-82026-02-25T16:04Zyearly https://clinicalinfo.hiv.gov/en/news/update-perinatal-hiv-clinical-guideline-02026-03-31T17:02Zyearly https://clinicalinfo.hiv.gov/en/node/134962026-04-08T15:11Zyearly https://clinicalinfo.hiv.gov/en/node/135012026-04-08T15:11Zyearly https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-announces-new-members2026-04-14T14:20Zmonthly https://clinicalinfo.hiv.gov/en/glossary/undetectable-untransmittable-uu2026-04-22T22:38Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/archive-mpox2026-04-29T15:58Zmonthly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv-32026-04-23T20:13Zmonthly https://clinicalinfo.hiv.gov/en/node/135412026-05-19T22:48Zmonthly https://clinicalinfo.hiv.gov/en/drugs/doravirine-islatravir/patient2026-05-21T17:29Zweekly https://clinicalinfo.hiv.gov/en/drugs/doravirine-islatravir/fda-labels2026-05-21T17:18Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/statin-therapy-people-hiv2026-05-27T14:58Zweekly https://clinicalinfo.hiv.gov/en/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-92026-06-01T20:51Zweekly https://clinicalinfo.hiv.gov/en/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-announces-changes-statin2026-05-27T19:34Zweekly https://clinicalinfo.hiv.gov/en/resources2022-12-06T16:30Znever https://clinicalinfo.hiv.gov/en/freedom-information-act-foia2022-06-08T14:42Znever https://clinicalinfo.hiv.gov/en/sponsors2022-12-06T17:13Znever https://clinicalinfo.hiv.gov/en/accessibility2024-09-24T16:28Zyearly https://clinicalinfo.hiv.gov/en/how-cite2026-02-20T16:35Zyearly https://clinicalinfo.hiv.gov/en/about-clinicalinfo2025-09-29T18:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv2026-05-27T15:00Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal2026-04-20T15:11Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections2026-04-23T20:04Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections2026-05-27T15:34Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv2026-04-20T18:49Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/guidance-caring-people-hiv-displaced-disasters2026-04-27T20:20Zmonthly https://clinicalinfo.hiv.gov/en/nondiscrimination-notice2022-12-06T17:14Znever https://clinicalinfo.hiv.gov/en/disclaimers2022-12-06T17:15Znever https://clinicalinfo.hiv.gov/en/node/62282026-03-13T14:44Zyearly https://clinicalinfo.hiv.gov/en/drugs/3bnc117/health-professional2026-03-13T14:45Zyearly https://clinicalinfo.hiv.gov/en/drugs/3bnc117/patient2026-03-25T19:48Zyearly https://clinicalinfo.hiv.gov/en/node/62342024-06-20T00:43Zyearly https://clinicalinfo.hiv.gov/en/drugs/abacavir-dolutegravir-lamivudine/fda-label2024-06-20T01:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/abacavir-dolutegravir-lamivudine/patient2026-02-20T23:15Zyearly https://clinicalinfo.hiv.gov/en/node/62402024-03-25T14:32Znever https://clinicalinfo.hiv.gov/en/drugs/abacavir-lamivudine/fda-label2024-06-15T02:08Zyearly https://clinicalinfo.hiv.gov/en/drugs/abacavir-lamivudine/patient2025-11-14T19:41Zyearly https://clinicalinfo.hiv.gov/en/node/62432026-01-13T23:32Zyearly https://clinicalinfo.hiv.gov/en/drugs/abacavir/fda-label2026-01-13T23:30Zyearly https://clinicalinfo.hiv.gov/en/drugs/abacavir/patient2026-01-13T23:40Zyearly https://clinicalinfo.hiv.gov/en/node/62462026-01-13T23:31Zyearly https://clinicalinfo.hiv.gov/en/node/62482024-06-10T19:03Zyearly https://clinicalinfo.hiv.gov/en/drugs/acyclovir/fda-label2024-06-20T02:45Zyearly https://clinicalinfo.hiv.gov/en/drugs/acyclovir/patient2026-03-27T17:21Zyearly https://clinicalinfo.hiv.gov/en/node/62542025-04-16T19:19Zyearly https://clinicalinfo.hiv.gov/en/drugs/albendazole/fda-label2025-04-16T19:19Zyearly https://clinicalinfo.hiv.gov/en/drugs/albendazole/patient2025-04-16T15:35Zyearly https://clinicalinfo.hiv.gov/en/node/62572026-04-16T15:46Zmonthly https://clinicalinfo.hiv.gov/en/drugs/albuvirtide/health-professional2026-04-17T01:53Zmonthly https://clinicalinfo.hiv.gov/en/drugs/albuvirtide/patient2026-04-17T01:50Zmonthly https://clinicalinfo.hiv.gov/en/node/62632025-09-24T19:42Zyearly https://clinicalinfo.hiv.gov/en/drugs/amphotericin-b/fda-label2025-09-24T23:38Zyearly https://clinicalinfo.hiv.gov/en/drugs/amphotericin-b/patient2026-02-19T02:07Zyearly https://clinicalinfo.hiv.gov/en/node/62682021-04-07T16:43Znever https://clinicalinfo.hiv.gov/en/drugs/atazanavir-cobicistat/fda-label2025-12-03T19:33Zyearly https://clinicalinfo.hiv.gov/en/drugs/atazanavir-cobicistat/patient2026-05-22T21:35Zweekly https://clinicalinfo.hiv.gov/en/node/62712024-05-16T17:15Znever https://clinicalinfo.hiv.gov/en/drugs/atazanavir/fda-label2024-06-15T02:11Zyearly https://clinicalinfo.hiv.gov/en/drugs/atazanavir/patient2026-05-29T13:39Zweekly https://clinicalinfo.hiv.gov/en/node/62742023-05-16T01:00Znever https://clinicalinfo.hiv.gov/en/node/62762025-01-13T19:43Zyearly https://clinicalinfo.hiv.gov/en/drugs/azithromycin/fda-label2024-06-21T01:12Zyearly https://clinicalinfo.hiv.gov/en/drugs/azithromycin/patient2025-03-28T22:06Zyearly https://clinicalinfo.hiv.gov/en/node/62802023-08-21T21:53Znever https://clinicalinfo.hiv.gov/en/drugs/bictegravir-emtricitabine-tenofovir-alafenamide/fda-label2026-01-29T23:11Zyearly https://clinicalinfo.hiv.gov/en/drugs/bictegravir-emtricitabine-tenofovir-alafenamide/patient2026-01-30T16:05Zyearly https://clinicalinfo.hiv.gov/en/node/62832021-03-22T15:16Znever https://clinicalinfo.hiv.gov/en/drugs/butoconazole-nitrate/fda-label2024-06-21T01:15Zyearly https://clinicalinfo.hiv.gov/en/drugs/butoconazole-nitrate/patient2026-02-21T00:58Zyearly https://clinicalinfo.hiv.gov/en/node/62952025-04-16T19:27Zyearly https://clinicalinfo.hiv.gov/en/drugs/ciprofloxacin/fda-label2024-06-21T01:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/ciprofloxacin/patient2026-02-20T00:17Zyearly https://clinicalinfo.hiv.gov/en/node/62992025-01-13T20:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/clarithromycin/fda-label2024-06-21T01:25Zyearly https://clinicalinfo.hiv.gov/en/drugs/clarithromycin/patient2025-03-28T21:54Zyearly https://clinicalinfo.hiv.gov/en/node/63042025-04-16T19:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/clindamycin/fda-label2025-04-16T19:23Zyearly https://clinicalinfo.hiv.gov/en/drugs/clindamycin/patient2026-02-20T23:13Zyearly https://clinicalinfo.hiv.gov/en/node/63172025-06-27T19:55Zyearly https://clinicalinfo.hiv.gov/en/drugs/darunavir-cobicistat-emtricitabine-tenofovir-alafenamide/fda-label2024-07-03T01:05Zyearly https://clinicalinfo.hiv.gov/en/drugs/darunavir-cobicistat-emtricitabine-tenofovir-alafenamide/patient2026-05-22T21:30Zweekly https://clinicalinfo.hiv.gov/en/node/63202026-03-24T15:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/darunavir-cobicistat/fda-label2026-03-24T19:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/darunavir-cobicistat/patient2026-05-22T21:34Zweekly https://clinicalinfo.hiv.gov/en/node/63232021-03-02T13:31Znever https://clinicalinfo.hiv.gov/en/drugs/darunavir/fda-label2024-11-08T03:36Zyearly https://clinicalinfo.hiv.gov/en/drugs/darunavir/patient2026-05-27T17:50Zweekly https://clinicalinfo.hiv.gov/en/node/63262022-11-21T02:31Znever https://clinicalinfo.hiv.gov/en/node/63362025-04-16T19:40Zyearly https://clinicalinfo.hiv.gov/en/drugs/dolutegravir-lamivudine/fda-label2025-04-16T19:40Zyearly https://clinicalinfo.hiv.gov/en/drugs/dolutegravir-lamivudine/patient2026-04-23T00:16Zmonthly https://clinicalinfo.hiv.gov/en/node/63392023-01-14T01:41Znever https://clinicalinfo.hiv.gov/en/drugs/dolutegravir-rilpivirine/fda-label2024-12-31T22:46Zyearly https://clinicalinfo.hiv.gov/en/drugs/dolutegravir-rilpivirine/patient2026-02-20T03:16Zyearly https://clinicalinfo.hiv.gov/en/node/63422024-03-08T18:20Znever https://clinicalinfo.hiv.gov/en/drugs/dolutegravir/fda-label2024-06-18T03:30Zyearly https://clinicalinfo.hiv.gov/en/drugs/dolutegravir/patient2026-02-23T19:16Zyearly https://clinicalinfo.hiv.gov/en/node/63452024-03-12T01:04Znever https://clinicalinfo.hiv.gov/en/node/63492021-04-07T16:36Znever https://clinicalinfo.hiv.gov/en/drugs/doravirinelamivudinetenofovir-disoproxil-fumarate/fda-label2024-11-07T03:06Zyearly https://clinicalinfo.hiv.gov/en/drugs/doravirinelamivudinetenofovir-disoproxil-fumarate/patient2025-12-01T20:38Zyearly https://clinicalinfo.hiv.gov/en/node/63522021-03-02T13:38Znever https://clinicalinfo.hiv.gov/en/drugs/doravirine/fda-label2024-11-26T01:54Zyearly https://clinicalinfo.hiv.gov/en/drugs/doravirine/patient2026-02-21T01:04Zyearly https://clinicalinfo.hiv.gov/en/node/63552022-11-21T21:12Znever https://clinicalinfo.hiv.gov/en/node/63572023-06-27T15:28Znever https://clinicalinfo.hiv.gov/en/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/fda-label2024-06-19T02:56Zyearly https://clinicalinfo.hiv.gov/en/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/patient2025-06-21T00:06Zyearly https://clinicalinfo.hiv.gov/en/node/63602025-06-30T22:45Zyearly https://clinicalinfo.hiv.gov/en/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/pt2025-07-01T19:46Zyearly https://clinicalinfo.hiv.gov/en/node/63652026-05-20T22:25Zweekly https://clinicalinfo.hiv.gov/en/drugs/efavirenz/fda-label2026-05-20T22:57Zweekly https://clinicalinfo.hiv.gov/en/drugs/efavirenz/patient2026-05-20T22:57Zweekly https://clinicalinfo.hiv.gov/en/node/63702023-11-16T01:23Znever https://clinicalinfo.hiv.gov/en/drugs/elbasvir-grazoprevir/fda-label2024-06-21T01:35Zyearly https://clinicalinfo.hiv.gov/en/drugs/elbasvir-grazoprevir/patient2026-02-20T00:01Zyearly https://clinicalinfo.hiv.gov/en/node/63732023-11-16T01:21Znever https://clinicalinfo.hiv.gov/en/node/63782024-11-14T20:35Zyearly https://clinicalinfo.hiv.gov/en/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide/fda-label2025-12-04T20:01Zyearly https://clinicalinfo.hiv.gov/en/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide/patient2026-05-22T21:32Zweekly https://clinicalinfo.hiv.gov/en/node/63812021-04-07T18:31Znever https://clinicalinfo.hiv.gov/en/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate/fda-label2024-10-26T01:13Zyearly https://clinicalinfo.hiv.gov/en/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate/patient2026-05-22T21:33Zweekly https://clinicalinfo.hiv.gov/en/node/63842024-01-31T00:12Znever https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-rilpivirine-tenofovir-alafenamide/fda-label2026-04-24T19:55Zmonthly https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-rilpivirine-tenofovir-alafenamide/patient2026-05-15T20:26Zmonthly https://clinicalinfo.hiv.gov/en/node/63872021-04-07T16:35Znever https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-rilpivirine-tenofovir-disoproxil-fumarate/fda-label2025-01-02T21:47Zyearly https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-rilpivirine-tenofovir-disoproxil-fumarate/patient2025-12-19T20:41Zyearly https://clinicalinfo.hiv.gov/en/node/63902024-02-09T17:46Znever https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-alafenamide/fda-label2026-01-16T19:40Zyearly https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-alafenamide/patient2026-01-22T20:57Zyearly https://clinicalinfo.hiv.gov/en/node/63932023-04-06T16:49Znever https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-disoproxil-fumarate/fda-label2024-06-20T02:39Zyearly https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-disoproxil-fumarate/patient2026-02-06T21:26Zyearly https://clinicalinfo.hiv.gov/en/node/63962021-03-02T13:42Znever https://clinicalinfo.hiv.gov/en/drugs/emtricitabine/fda-label2025-01-02T23:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/emtricitabine/patient2026-02-20T23:12Zyearly https://clinicalinfo.hiv.gov/en/node/63992023-12-28T02:37Znever https://clinicalinfo.hiv.gov/en/node/64042024-12-26T22:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/ethambutol-hydrochloride/fda-label2024-12-26T22:29Zyearly https://clinicalinfo.hiv.gov/en/drugs/ethambutol-hydrochloride/patient2026-02-20T02:47Zyearly https://clinicalinfo.hiv.gov/en/node/64072021-03-02T13:45Znever https://clinicalinfo.hiv.gov/en/drugs/etravirine/fda-label2024-12-30T23:56Zyearly https://clinicalinfo.hiv.gov/en/drugs/etravirine/patient2025-12-12T23:10Zyearly https://clinicalinfo.hiv.gov/en/node/64102022-10-19T16:59Znever https://clinicalinfo.hiv.gov/en/node/64122023-04-27T01:16Znever https://clinicalinfo.hiv.gov/en/drugs/famciclovir/fda-label2024-06-21T01:47Zyearly https://clinicalinfo.hiv.gov/en/drugs/famciclovir/patient2026-03-27T17:16Zyearly https://clinicalinfo.hiv.gov/en/node/64152025-04-29T23:42Zyearly https://clinicalinfo.hiv.gov/en/drugs/fluconazole/fda-label2025-04-29T23:41Zyearly https://clinicalinfo.hiv.gov/en/drugs/fluconazole/patient2026-02-19T23:44Zyearly https://clinicalinfo.hiv.gov/en/node/64192021-03-22T15:20Znever https://clinicalinfo.hiv.gov/en/drugs/flucytosine/fda-label2024-06-21T01:58Zyearly https://clinicalinfo.hiv.gov/en/drugs/flucytosine/patient2026-02-20T03:14Zyearly https://clinicalinfo.hiv.gov/en/node/64222024-02-26T15:54Znever https://clinicalinfo.hiv.gov/en/drugs/fosamprenavir/fda-label2024-06-19T03:05Zyearly https://clinicalinfo.hiv.gov/en/drugs/fosamprenavir/patient2026-02-20T01:22Zyearly https://clinicalinfo.hiv.gov/en/node/64272023-03-01T22:29Znever https://clinicalinfo.hiv.gov/en/drugs/foscarnet-sodium/fda-label2024-06-21T02:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/foscarnet-sodium/patient2026-02-20T00:07Zyearly https://clinicalinfo.hiv.gov/en/node/64302024-07-12T14:09Zyearly https://clinicalinfo.hiv.gov/en/drugs/fostemsavir/fda-label2025-07-09T00:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/fostemsavir/patient2025-07-08T23:49Zyearly https://clinicalinfo.hiv.gov/en/node/64332023-08-23T00:02Znever https://clinicalinfo.hiv.gov/en/node/64372025-08-11T18:50Zyearly https://clinicalinfo.hiv.gov/en/drugs/ganciclovir/fda-label2025-08-11T18:52Zyearly https://clinicalinfo.hiv.gov/en/drugs/ganciclovir-injection/patient2026-02-20T23:21Zyearly https://clinicalinfo.hiv.gov/en/node/64402023-09-22T01:03Znever https://clinicalinfo.hiv.gov/en/drugs/glecaprevir-pibrentasvir/fda-label2024-06-21T02:19Zyearly https://clinicalinfo.hiv.gov/en/drugs/glecaprevir-pibrentasvir/patient2026-02-19T03:17Zyearly https://clinicalinfo.hiv.gov/en/node/64432023-03-08T21:59Znever https://clinicalinfo.hiv.gov/en/drugs/hepatitis-and-hepatitis-b-recombinant-vaccine/fda-label2025-01-15T20:34Zyearly https://clinicalinfo.hiv.gov/en/drugs/hepatitis-and-hepatitis-b-recombinant-vaccine/patient2026-02-20T22:55Zyearly https://clinicalinfo.hiv.gov/en/node/64462024-06-13T02:44Zyearly https://clinicalinfo.hiv.gov/en/drugs/hepatitis-b-vaccine/fda-label2025-01-15T20:30Zyearly https://clinicalinfo.hiv.gov/en/drugs/hepatitis-b-vaccine/patient2026-02-20T03:01Zyearly https://clinicalinfo.hiv.gov/en/node/64512023-09-18T17:54Znever https://clinicalinfo.hiv.gov/en/drugs/human-papillomavirus-9-valent-vaccine-recombinant/fda-label2025-01-15T20:33Zyearly https://clinicalinfo.hiv.gov/en/drugs/human-papillomavirus-9-valent-vaccine-recombinant/patient2025-09-03T00:25Zyearly https://clinicalinfo.hiv.gov/en/node/64542023-09-18T17:54Znever https://clinicalinfo.hiv.gov/en/node/64602022-04-07T08:35Znever https://clinicalinfo.hiv.gov/en/drugs/ibalizumab-uiyk/fda-label2024-06-20T01:58Zyearly https://clinicalinfo.hiv.gov/en/drugs/ibalizumab-uiyk/patient2026-01-20T20:19Zyearly https://clinicalinfo.hiv.gov/en/node/64632022-10-19T22:13Znever https://clinicalinfo.hiv.gov/en/node/64652023-04-13T01:58Znever https://clinicalinfo.hiv.gov/en/drugs/imiquimod/fda-label2024-06-21T02:27Zyearly https://clinicalinfo.hiv.gov/en/drugs/imiquimod/patient2026-02-20T23:18Zyearly https://clinicalinfo.hiv.gov/en/node/64722024-06-13T18:21Zyearly https://clinicalinfo.hiv.gov/en/drugs/isoniazid/fda-label2024-06-21T02:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/isoniazid/patient2026-02-20T02:39Zyearly https://clinicalinfo.hiv.gov/en/node/64772025-06-20T22:32Zyearly https://clinicalinfo.hiv.gov/en/drugs/itraconazole/fda-label2025-06-20T22:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/itraconazole/patient2026-02-19T23:08Zyearly https://clinicalinfo.hiv.gov/en/node/64842025-04-25T23:30Zyearly https://clinicalinfo.hiv.gov/en/drugs/lamivudine-tenofovir-disoproxil-fumarate/fda-label2025-04-25T23:29Zyearly https://clinicalinfo.hiv.gov/en/drugs/lamivudine-tenofovir-disoproxil-fumarate/patient2026-03-02T19:30Zyearly https://clinicalinfo.hiv.gov/en/node/64872024-04-10T19:26Znever https://clinicalinfo.hiv.gov/en/drugs/lamivudine-zidovudine/fda-label2024-06-20T02:03Zyearly https://clinicalinfo.hiv.gov/en/drugs/lamivudine-zidovudine/patient2025-12-17T23:51Zyearly https://clinicalinfo.hiv.gov/en/node/64902023-06-06T22:01Znever https://clinicalinfo.hiv.gov/en/drugs/lamivudine/fda-label2024-06-20T01:21Zyearly https://clinicalinfo.hiv.gov/en/drugs/lamivudine/patient2025-06-12T01:34Zyearly https://clinicalinfo.hiv.gov/en/node/64932023-06-06T22:02Znever https://clinicalinfo.hiv.gov/en/node/64952023-05-23T19:40Znever https://clinicalinfo.hiv.gov/en/drugs/ledipasvirsofosbuvir/fda-label2024-06-21T02:37Zyearly https://clinicalinfo.hiv.gov/en/drugs/ledipasvirsofosbuvir/patient2026-02-20T02:52Zyearly https://clinicalinfo.hiv.gov/en/node/64982022-05-11T14:35Znever https://clinicalinfo.hiv.gov/en/drugs/lefitolimod/health-professional2025-07-25T18:53Zyearly https://clinicalinfo.hiv.gov/en/drugs/lefitolimod/patient2025-07-25T18:53Zyearly https://clinicalinfo.hiv.gov/en/node/65042025-04-16T19:37Zyearly https://clinicalinfo.hiv.gov/en/drugs/levofloxacin/fda-label2025-04-16T19:37Zyearly https://clinicalinfo.hiv.gov/en/drugs/levofloxacin/patient2026-02-20T03:05Zyearly https://clinicalinfo.hiv.gov/en/node/65122023-07-20T01:20Znever https://clinicalinfo.hiv.gov/en/drugs/lopinavir-ritonavir/fda-label2025-07-09T19:18Zyearly https://clinicalinfo.hiv.gov/en/drugs/lopinavir-ritonavir/patient2026-02-18T21:42Zyearly https://clinicalinfo.hiv.gov/en/node/65182025-12-12T23:19Zyearly https://clinicalinfo.hiv.gov/en/drugs/maraviroc/fda-label2025-12-12T23:20Zyearly https://clinicalinfo.hiv.gov/en/drugs/maraviroc/patient2026-02-20T00:04Zyearly https://clinicalinfo.hiv.gov/en/node/65212025-12-12T23:18Zyearly https://clinicalinfo.hiv.gov/en/node/65232025-04-16T19:39Zyearly https://clinicalinfo.hiv.gov/en/drugs/miconazole/fda-label2025-04-16T19:39Zyearly https://clinicalinfo.hiv.gov/en/drugs/miconazole/patient2026-02-20T03:07Zyearly https://clinicalinfo.hiv.gov/en/node/65262025-07-02T02:45Zyearly https://clinicalinfo.hiv.gov/en/drugs/moxifloxacin-hydrochloride/fda-label2024-06-21T02:43Zyearly https://clinicalinfo.hiv.gov/en/drugs/moxifloxacin-hydrochloride/patient2025-07-02T03:08Zyearly https://clinicalinfo.hiv.gov/en/node/65302024-06-12T20:00Zyearly https://clinicalinfo.hiv.gov/en/drugs/nevirapine/fda-label2024-06-20T02:12Zyearly https://clinicalinfo.hiv.gov/en/drugs/nevirapine/patient2026-04-09T17:42Zmonthly https://clinicalinfo.hiv.gov/en/node/65432025-05-23T16:07Zyearly https://clinicalinfo.hiv.gov/en/drugs/panobinostat/health-professional2026-05-19T22:19Zmonthly https://clinicalinfo.hiv.gov/en/drugs/panobinostat/patient2026-05-19T22:25Zmonthly https://clinicalinfo.hiv.gov/en/node/65602024-09-07T03:26Zyearly https://clinicalinfo.hiv.gov/en/drugs/primaquine-phosphate/fda-label2024-06-21T03:20Zyearly https://clinicalinfo.hiv.gov/en/drugs/primaquine-phosphate/patient2025-03-28T21:56Zyearly https://clinicalinfo.hiv.gov/en/node/65632026-02-18T19:44Zyearly https://clinicalinfo.hiv.gov/en/drugs/pyrazinamide/fda-label2026-02-18T19:52Zyearly https://clinicalinfo.hiv.gov/en/drugs/pyrazinamide/patient2026-02-18T19:51Zyearly https://clinicalinfo.hiv.gov/en/node/65692022-12-03T01:21Znever https://clinicalinfo.hiv.gov/en/drugs/pyrimethamine/fda-label2024-06-22T01:16Zyearly https://clinicalinfo.hiv.gov/en/drugs/pyrimethamine/patient2025-03-28T22:06Zyearly https://clinicalinfo.hiv.gov/en/drugs/raltegravir/fda-label2025-07-11T23:27Zyearly https://clinicalinfo.hiv.gov/en/drugs/raltegravir/patient2025-07-11T23:29Zyearly https://clinicalinfo.hiv.gov/en/node/65752025-07-11T23:29Zyearly https://clinicalinfo.hiv.gov/en/node/65772025-07-11T23:28Zyearly https://clinicalinfo.hiv.gov/en/node/65792024-11-27T02:14Zyearly https://clinicalinfo.hiv.gov/en/drugs/ribavirin/fda-label2024-06-22T01:18Zyearly https://clinicalinfo.hiv.gov/en/drugs/ribavirin/patient2025-03-28T22:04Zyearly https://clinicalinfo.hiv.gov/en/node/65832026-02-18T01:53Zyearly https://clinicalinfo.hiv.gov/en/drugs/rifabutin/fda-label2026-02-18T02:28Zyearly https://clinicalinfo.hiv.gov/en/drugs/rifabutin/patient2026-02-21T01:01Zyearly https://clinicalinfo.hiv.gov/en/node/65862024-06-13T20:03Zyearly https://clinicalinfo.hiv.gov/en/drugs/rifampin/patient2026-02-20T01:24Zyearly https://clinicalinfo.hiv.gov/en/node/65892024-04-04T16:07Znever https://clinicalinfo.hiv.gov/en/drugs/rilpivirine/fda-label2024-06-20T02:26Zyearly https://clinicalinfo.hiv.gov/en/drugs/rilpivirine/patient2026-05-08T19:24Zmonthly https://clinicalinfo.hiv.gov/en/node/65922024-04-04T16:08Znever https://clinicalinfo.hiv.gov/en/node/65942026-05-28T23:59Zweekly https://clinicalinfo.hiv.gov/en/drugs/ritonavir/fda-label2026-05-29T00:00Zweekly https://clinicalinfo.hiv.gov/en/drugs/ritonavir/patient2026-05-29T13:46Zweekly https://clinicalinfo.hiv.gov/en/node/65972026-05-28T23:59Zweekly https://clinicalinfo.hiv.gov/en/node/65992024-04-09T20:50Znever https://clinicalinfo.hiv.gov/en/drugs/romidepsin/health-professional2026-05-04T19:24Zmonthly https://clinicalinfo.hiv.gov/en/drugs/romidepsin/patient2026-05-04T19:23Zmonthly https://clinicalinfo.hiv.gov/en/node/66022025-01-14T22:25Zyearly https://clinicalinfo.hiv.gov/en/drugs/sb-728-t/health-professional2026-04-03T23:24Zyearly https://clinicalinfo.hiv.gov/en/drugs/sb-728-t/patient2026-04-03T23:36Zyearly https://clinicalinfo.hiv.gov/en/node/66102024-10-29T20:18Zyearly https://clinicalinfo.hiv.gov/en/drugs/sinecatechins/fda-label2024-10-29T20:17Zyearly https://clinicalinfo.hiv.gov/en/drugs/sinecatechins/patient2026-02-20T23:16Zyearly https://clinicalinfo.hiv.gov/en/node/66132024-08-28T19:25Zyearly https://clinicalinfo.hiv.gov/en/drugs/sofosbuvir-velpatasvir-voxilaprevir/fda-label2024-06-22T01:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/sofosbuvir-velpatasvir-voxilaprevir/patient2025-03-28T21:56Zyearly https://clinicalinfo.hiv.gov/en/node/66162020-11-26T18:12Znever https://clinicalinfo.hiv.gov/en/drugs/sofosbuvir-velpatasvir-voxilaprevir/patient-02020-11-27T00:24Znever https://clinicalinfo.hiv.gov/en/node/66182023-07-26T00:52Znever https://clinicalinfo.hiv.gov/en/drugs/sofosbuvirvelpatasvir/fda-label2024-06-22T01:29Zyearly https://clinicalinfo.hiv.gov/en/drugs/sofosbuvirvelpatasvir/patient2025-07-16T21:52Zyearly https://clinicalinfo.hiv.gov/en/node/66212021-04-12T16:10Znever https://clinicalinfo.hiv.gov/en/drugs/sofosbuvir/fda-label2024-06-22T01:28Zyearly https://clinicalinfo.hiv.gov/en/drugs/sofosbuvir/patient2026-02-19T23:55Zyearly https://clinicalinfo.hiv.gov/en/node/66272024-07-26T03:33Zyearly https://clinicalinfo.hiv.gov/en/drugs/sulfadiazine/fda-label2024-07-26T03:32Zyearly https://clinicalinfo.hiv.gov/en/drugs/sulfadiazine/patient2025-03-28T22:07Zyearly https://clinicalinfo.hiv.gov/en/node/66302025-04-16T19:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/sulfamethoxazole-trimethoprim/fda-label2025-04-16T19:31Zyearly https://clinicalinfo.hiv.gov/en/drugs/sulfamethoxazole-trimethoprim/patient2026-02-20T02:54Zyearly https://clinicalinfo.hiv.gov/en/node/66382021-03-02T18:02Znever https://clinicalinfo.hiv.gov/en/drugs/tenofovir-disoproxil-fumarate/fda-label2024-06-20T02:36Zyearly https://clinicalinfo.hiv.gov/en/drugs/tenofovir-disoproxil-fumarate/patient2026-05-08T20:23Zmonthly https://clinicalinfo.hiv.gov/en/node/66412023-04-14T02:22Znever https://clinicalinfo.hiv.gov/en/node/66432025-09-25T20:10Zyearly https://clinicalinfo.hiv.gov/en/drugs/tenofovir-based-microbicides/health-professional2025-09-25T20:09Zyearly https://clinicalinfo.hiv.gov/en/drugs/tenofovir-based-microbicides/patient2026-02-20T03:09Zyearly https://clinicalinfo.hiv.gov/en/node/66462024-06-13T20:19Zyearly https://clinicalinfo.hiv.gov/en/drugs/terconazole/fda-label2024-06-22T01:37Zyearly https://clinicalinfo.hiv.gov/en/drugs/terconazole/patient2025-04-16T15:35Zyearly https://clinicalinfo.hiv.gov/en/node/66502024-06-11T23:11Zyearly https://clinicalinfo.hiv.gov/en/drugs/tipranavir/fda-label2024-06-20T02:38Zyearly https://clinicalinfo.hiv.gov/en/drugs/tipranavir/patient2026-02-21T01:00Zyearly https://clinicalinfo.hiv.gov/en/node/66532024-06-11T23:10Zyearly https://clinicalinfo.hiv.gov/en/node/66552025-04-16T19:30Zyearly https://clinicalinfo.hiv.gov/en/drugs/tucidinostat/health-professional2026-04-20T19:16Zmonthly https://clinicalinfo.hiv.gov/en/drugs/tucidinostat/patient2026-04-20T19:17Zmonthly https://clinicalinfo.hiv.gov/en/node/66582024-10-09T01:14Zyearly https://clinicalinfo.hiv.gov/en/drugs/ub-421/health-professional2025-12-29T18:09Zyearly https://clinicalinfo.hiv.gov/en/drugs/ub-421/patient2026-02-20T02:44Zyearly https://clinicalinfo.hiv.gov/en/node/66612026-03-13T00:40Zyearly https://clinicalinfo.hiv.gov/en/drugs/vrc01/health-professional2026-03-13T00:40Zyearly https://clinicalinfo.hiv.gov/en/drugs/vrc01/patient2026-03-13T18:26Zyearly https://clinicalinfo.hiv.gov/en/node/66642021-03-22T17:18Znever https://clinicalinfo.hiv.gov/en/drugs/valacyclovir-hydrochloride/fda-label2024-06-22T01:38Zyearly https://clinicalinfo.hiv.gov/en/drugs/valacyclovir-hydrochloride/patient2026-03-27T17:19Zyearly https://clinicalinfo.hiv.gov/en/node/66672026-02-18T02:34Zyearly https://clinicalinfo.hiv.gov/en/drugs/valganciclovir-hydrochloride/fda-label2026-02-18T02:55Zyearly https://clinicalinfo.hiv.gov/en/drugs/valganciclovir-hydrochloride/patient2026-02-18T02:51Zyearly https://clinicalinfo.hiv.gov/en/node/66732025-01-13T20:28Zyearly https://clinicalinfo.hiv.gov/en/drugs/vancomycin-hydrochloride/fda-label2024-06-22T01:41Zyearly https://clinicalinfo.hiv.gov/en/drugs/vancomycin-hydrochloride/patient2026-02-20T00:24Zyearly https://clinicalinfo.hiv.gov/en/node/66772022-10-05T22:12Znever https://clinicalinfo.hiv.gov/en/drugs/varicella-virus-vaccine-live/fda-label2025-01-15T20:55Zyearly https://clinicalinfo.hiv.gov/en/drugs/varicella-virus-vaccine-live/patient2026-02-20T22:53Zyearly https://clinicalinfo.hiv.gov/en/node/66802023-04-17T23:10Znever https://clinicalinfo.hiv.gov/en/node/66822026-02-18T03:08Zyearly https://clinicalinfo.hiv.gov/en/drugs/varicella-zoster-immune-globulin-human/fda-label2026-02-18T03:26Zyearly https://clinicalinfo.hiv.gov/en/drugs/varicella-zoster-immune-globulin-human/patient2026-02-18T03:24Zyearly https://clinicalinfo.hiv.gov/en/node/66852026-02-18T03:07Zyearly https://clinicalinfo.hiv.gov/en/drugs/varicella-zoster-immune-globulin-human/patient-02020-11-27T00:24Znever https://clinicalinfo.hiv.gov/en/node/66872025-04-16T19:24Zyearly https://clinicalinfo.hiv.gov/en/drugs/vedolizumab/health-professional2026-04-07T00:16Zyearly https://clinicalinfo.hiv.gov/en/drugs/vedolizumab/patient2026-04-07T00:22Zyearly https://clinicalinfo.hiv.gov/en/node/66932026-01-13T21:01Zyearly https://clinicalinfo.hiv.gov/en/drugs/vorinostat/patient2026-01-13T23:21Zyearly https://clinicalinfo.hiv.gov/en/node/66962024-06-12T20:17Zyearly https://clinicalinfo.hiv.gov/en/drugs/zidovudine/fda-label2024-06-20T02:41Zyearly https://clinicalinfo.hiv.gov/en/drugs/zidovudine/patient2026-02-19T02:23Zyearly https://clinicalinfo.hiv.gov/en/node/67002024-06-12T20:17Zyearly https://clinicalinfo.hiv.gov/en/node/67022025-09-10T20:07Zyearly https://clinicalinfo.hiv.gov/en/drugs/zoster-vaccine-recombinant-adjuvanted/fda-label2025-09-10T20:06Zyearly https://clinicalinfo.hiv.gov/en/drugs/zoster-vaccine-recombinant-adjuvanted/patient2025-09-10T20:04Zyearly https://clinicalinfo.hiv.gov/en/node/67052025-09-10T20:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/acquired-immunity2024-01-31T16:09Znever https://clinicalinfo.hiv.gov/en/glossary/acquired-immunodeficiency-syndrome-aids2024-06-28T21:29Zyearly https://clinicalinfo.hiv.gov/en/glossary/active-immunity2024-02-01T18:29Znever https://clinicalinfo.hiv.gov/en/glossary/acute-hiv-infection2024-10-24T02:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/adjuvant2024-02-01T18:32Znever https://clinicalinfo.hiv.gov/en/glossary/agammaglobulinemia2024-02-01T18:33Znever https://clinicalinfo.hiv.gov/en/glossary/agency-healthcare-research-and-quality-ahrq2024-02-01T18:33Znever https://clinicalinfo.hiv.gov/en/glossary/aids-dementia-complex-adc2024-10-24T03:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/aids-drug-assistance-program-adap2024-10-24T02:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/aids-education-and-training-center-aetc2024-10-24T02:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/aids-service-organization-aso2024-08-09T18:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/aids-related-cancer2024-08-09T18:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/amino-acids2024-02-01T18:36Znever https://clinicalinfo.hiv.gov/en/glossary/anemia2024-02-01T18:37Znever https://clinicalinfo.hiv.gov/en/glossary/antibiotic2024-02-01T18:38Znever https://clinicalinfo.hiv.gov/en/glossary/antibody2024-02-01T18:38Znever https://clinicalinfo.hiv.gov/en/glossary/antifungal2024-02-01T18:39Znever https://clinicalinfo.hiv.gov/en/glossary/antigen2024-02-01T18:40Znever https://clinicalinfo.hiv.gov/en/glossary/antigen-presenting-cell-apc2024-02-01T18:46Znever https://clinicalinfo.hiv.gov/en/glossary/antineoplastic2024-02-01T18:47Znever https://clinicalinfo.hiv.gov/en/glossary/antiprotozoal2024-02-01T18:47Znever https://clinicalinfo.hiv.gov/en/glossary/antisense-antiviral2024-02-01T18:48Znever https://clinicalinfo.hiv.gov/en/glossary/antiviral2024-02-01T18:49Znever https://clinicalinfo.hiv.gov/en/glossary/aphthous-ulcer2024-06-29T00:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/apoptosis2024-06-29T00:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/approved-drug2024-06-29T01:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/arm2024-02-01T18:51Znever https://clinicalinfo.hiv.gov/en/glossary/arthralgia2024-06-29T01:08Zyearly https://clinicalinfo.hiv.gov/en/glossary/aspergillosis2024-02-01T18:53Znever https://clinicalinfo.hiv.gov/en/glossary/ataxia2024-02-01T18:54Znever https://clinicalinfo.hiv.gov/en/glossary/live-attenuated2024-02-01T18:56Znever https://clinicalinfo.hiv.gov/en/glossary/avascular-necrosis-avn2024-06-29T01:09Zyearly https://clinicalinfo.hiv.gov/en/glossary/b-cell-lymphoma2024-10-24T02:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/b-lymphocyte2024-08-13T03:09Zyearly https://clinicalinfo.hiv.gov/en/glossary/bactericidal-drug2024-02-01T19:00Znever https://clinicalinfo.hiv.gov/en/glossary/bacteriostatic-drug2024-02-01T19:01Znever https://clinicalinfo.hiv.gov/en/glossary/bacterium2024-06-29T01:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/baseline2024-02-01T19:02Znever https://clinicalinfo.hiv.gov/en/glossary/basophil2024-02-01T19:02Znever https://clinicalinfo.hiv.gov/en/glossary/beta-2-microglobulin-b2m2024-02-01T19:03Znever https://clinicalinfo.hiv.gov/en/glossary/bilirubin2024-02-01T19:03Znever https://clinicalinfo.hiv.gov/en/glossary/bioavailability2024-02-01T19:04Znever https://clinicalinfo.hiv.gov/en/glossary/biopsy2024-02-01T19:05Znever https://clinicalinfo.hiv.gov/en/glossary/blip2024-02-01T19:05Znever https://clinicalinfo.hiv.gov/en/glossary/blood-brain-barrier2024-08-19T14:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/boosting2024-02-01T19:09Znever https://clinicalinfo.hiv.gov/en/glossary/bronchoscopy2024-02-01T19:12Znever https://clinicalinfo.hiv.gov/en/glossary/burkitt-lymphoma2024-02-01T19:13Znever https://clinicalinfo.hiv.gov/en/glossary/cachexia2024-02-12T22:33Znever https://clinicalinfo.hiv.gov/en/glossary/candidiasis2024-02-01T18:31Znever https://clinicalinfo.hiv.gov/en/glossary/ccr52024-08-06T19:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-t-lymphocyte2024-08-13T03:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/cell-mediated-immunity2024-08-06T19:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/centers-disease-control-and-prevention-cdc2024-02-01T19:48Znever https://clinicalinfo.hiv.gov/en/glossary/centers-medicare-and-medicaid-services-cms2024-02-01T19:49Znever https://clinicalinfo.hiv.gov/en/glossary/central-nervous-system-cns2024-06-29T01:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/cerebrospinal-fluid-csf2024-02-01T19:49Znever https://clinicalinfo.hiv.gov/en/glossary/cervical-cancer2025-04-09T19:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/cervix2024-02-01T19:50Znever https://clinicalinfo.hiv.gov/en/glossary/chancroid2024-06-29T02:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/chemokines2024-02-01T17:47Znever https://clinicalinfo.hiv.gov/en/glossary/chemotherapy2024-10-24T02:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/chlamydia2024-06-29T02:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/chronic-inflammatory-demyelinating-polyneuropathy-cidp2024-07-02T02:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/clinical-alert2024-02-01T20:00Znever https://clinicalinfo.hiv.gov/en/glossary/clinical-trial2024-02-14T18:38Znever https://clinicalinfo.hiv.gov/en/glossary/clinicaltrialsgov2024-08-06T19:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/coccidioidomycosis2024-02-01T18:42Znever https://clinicalinfo.hiv.gov/en/glossary/cognitive-impairment2024-02-01T20:06Znever https://clinicalinfo.hiv.gov/en/glossary/cohort2024-07-02T02:28Zyearly https://clinicalinfo.hiv.gov/en/glossary/colitis2024-07-02T02:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/community-based-organization-cbo2024-08-13T03:59Zyearly https://clinicalinfo.hiv.gov/en/glossary/complementary-and-alternative-medicine-cam2024-02-01T20:16Znever https://clinicalinfo.hiv.gov/en/glossary/complete-blood-count-cbc2024-02-01T20:16Znever https://clinicalinfo.hiv.gov/en/glossary/contagious-disease2024-02-01T20:18Znever https://clinicalinfo.hiv.gov/en/glossary/contraindication2024-02-01T20:19Znever https://clinicalinfo.hiv.gov/en/glossary/controlled-trial2024-02-01T20:20Znever https://clinicalinfo.hiv.gov/en/glossary/capsid2024-02-05T16:33Znever https://clinicalinfo.hiv.gov/en/glossary/coreceptor2021-06-01T22:32Znever https://clinicalinfo.hiv.gov/en/glossary/cross-resistance2024-08-13T04:01Zyearly https://clinicalinfo.hiv.gov/en/glossary/cryotherapy2024-02-01T20:24Znever https://clinicalinfo.hiv.gov/en/glossary/cryptococcal-meningitis2024-02-01T20:25Znever https://clinicalinfo.hiv.gov/en/glossary/cryptococcosis2024-02-01T19:40Znever https://clinicalinfo.hiv.gov/en/glossary/cryptosporidiosis2024-07-02T02:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/cryptosporidium2024-02-01T20:27Znever https://clinicalinfo.hiv.gov/en/glossary/cutaneous2024-02-01T20:28Znever https://clinicalinfo.hiv.gov/en/glossary/cxcr42024-08-06T19:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/cytokine2024-02-01T20:30Znever https://clinicalinfo.hiv.gov/en/glossary/cytomegalovirus-cmv2024-02-01T20:30Znever https://clinicalinfo.hiv.gov/en/glossary/cytomegalovirus-retinitis2024-02-01T19:24Znever https://clinicalinfo.hiv.gov/en/glossary/cytopenia2024-02-01T20:31Znever https://clinicalinfo.hiv.gov/en/glossary/cytotoxic2024-02-01T20:31Znever https://clinicalinfo.hiv.gov/en/glossary/data-and-safety-monitoring-board-dsmb2024-10-24T02:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/dendritic-cell2024-02-01T21:00Znever https://clinicalinfo.hiv.gov/en/glossary/deoxyribonucleic-acid-dna2024-02-01T21:00Znever https://clinicalinfo.hiv.gov/en/glossary/us-department-health-and-human-services-hhs2024-08-17T03:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/desensitization2024-02-01T21:01Znever https://clinicalinfo.hiv.gov/en/glossary/diabetes2024-07-02T02:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/division-acquired-immunodeficiency-syndrome-daids2024-07-02T02:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/dose-response-relationship2024-08-06T19:56Zyearly https://clinicalinfo.hiv.gov/en/glossary/double-blind-study2024-07-29T20:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-resistance2024-07-02T03:01Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-drug-interaction2024-08-08T20:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/dyspnea2024-02-13T00:33Znever https://clinicalinfo.hiv.gov/en/glossary/efficacy2024-02-01T21:12Znever https://clinicalinfo.hiv.gov/en/glossary/enzyme-linked-immunosorbent-assay-elisa2024-08-08T20:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/encephalitis2024-07-02T03:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/endemic2024-02-01T21:15Znever https://clinicalinfo.hiv.gov/en/glossary/enteric2024-02-01T21:16Znever https://clinicalinfo.hiv.gov/en/glossary/enteritis2024-02-01T21:17Znever https://clinicalinfo.hiv.gov/en/glossary/envelope2024-02-13T00:35Znever https://clinicalinfo.hiv.gov/en/glossary/enzyme2024-02-01T21:19Znever https://clinicalinfo.hiv.gov/en/glossary/eosinophilic-folliculitis-ef2024-07-02T03:09Zyearly https://clinicalinfo.hiv.gov/en/glossary/epidemic2024-02-01T21:21Znever https://clinicalinfo.hiv.gov/en/glossary/epidemiology2024-02-01T21:22Znever https://clinicalinfo.hiv.gov/en/glossary/epithelium2024-02-01T21:22Znever https://clinicalinfo.hiv.gov/en/glossary/epitope2024-02-01T21:22Znever https://clinicalinfo.hiv.gov/en/glossary/epstein-barr-virus-ebv2024-08-08T20:25Zyearly https://clinicalinfo.hiv.gov/en/glossary/erythema2024-02-01T21:24Znever https://clinicalinfo.hiv.gov/en/glossary/erythema-multiforme2024-02-01T21:24Znever https://clinicalinfo.hiv.gov/en/glossary/red-blood-cell2024-08-17T02:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/etiology2024-02-01T21:25Znever https://clinicalinfo.hiv.gov/en/glossary/us-food-and-drug-administration-fda2024-08-17T03:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/fungus2024-07-02T03:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/fusion-inhibitor2024-02-01T20:38Znever https://clinicalinfo.hiv.gov/en/glossary/gamma-globulin2024-02-01T21:43Znever https://clinicalinfo.hiv.gov/en/glossary/gastrointestinal-gi2024-07-02T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/gene2024-02-01T21:44Znever https://clinicalinfo.hiv.gov/en/glossary/gene-therapy2024-02-01T21:45Znever https://clinicalinfo.hiv.gov/en/glossary/genetic-engineering2024-02-01T21:45Znever https://clinicalinfo.hiv.gov/en/glossary/genital-ulcer-disease2024-07-02T03:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/genital-warts2024-07-02T03:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/genitourinary-tract2024-02-01T19:27Znever https://clinicalinfo.hiv.gov/en/glossary/genome2024-02-01T21:47Znever https://clinicalinfo.hiv.gov/en/glossary/genotypic-antiretroviral-resistance-test-gart2024-02-01T21:47Znever https://clinicalinfo.hiv.gov/en/glossary/glycoprotein-gp2024-10-24T02:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/gonorrhea2025-04-09T18:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/gp1202024-10-29T02:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/gp1602025-08-07T21:21Zyearly https://clinicalinfo.hiv.gov/en/glossary/gp412024-10-29T02:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/granulocyte2024-02-01T21:50Znever https://clinicalinfo.hiv.gov/en/glossary/granulocyte-macrophage-colony-stimulating-factor-gm-csf2024-10-29T02:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/granulocyte-colony-stimulating-factor-g-csf2024-10-29T02:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/granulocytopenia2024-02-01T21:51Znever https://clinicalinfo.hiv.gov/en/glossary/half-life-t-122024-08-15T02:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/health-resources-and-services-administration-hrsa2024-07-03T01:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/hellp-syndrome2024-07-29T14:08Zyearly https://clinicalinfo.hiv.gov/en/glossary/hematocrit-hct2024-10-24T02:59Zyearly https://clinicalinfo.hiv.gov/en/glossary/hematotoxic2024-02-05T18:30Znever https://clinicalinfo.hiv.gov/en/glossary/hemoglobin2024-02-05T22:04Znever https://clinicalinfo.hiv.gov/en/glossary/hemolysis2024-02-05T18:32Znever https://clinicalinfo.hiv.gov/en/glossary/hemophilia2024-02-05T22:05Znever https://clinicalinfo.hiv.gov/en/glossary/hepatic2024-02-05T18:33Znever https://clinicalinfo.hiv.gov/en/glossary/hepatomegaly2024-02-13T01:04Znever https://clinicalinfo.hiv.gov/en/glossary/herpes-simplex-virus-1-hsv-1-infection2024-07-03T01:56Zyearly https://clinicalinfo.hiv.gov/en/glossary/herpes-simplex-virus-2-hsv-2-infection2024-07-03T01:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/herpesviruses2024-02-03T15:05Znever https://clinicalinfo.hiv.gov/en/glossary/histoplasmosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-vaccine-trials-network-hvtn2024-08-15T02:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-12025-02-10T17:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/hodgkin-lymphoma2024-02-05T19:23Znever https://clinicalinfo.hiv.gov/en/glossary/hormone2024-02-05T18:35Znever https://clinicalinfo.hiv.gov/en/glossary/human-growth-hormone-hgh2024-07-03T02:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-immunodeficiency-virus-hiv2025-02-10T17:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-papillomavirus-hpv2025-04-09T18:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-t-cell-lymphotropic-virus-type-1-htlv-12025-04-09T19:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/humoral-immunity2024-02-03T15:14Znever https://clinicalinfo.hiv.gov/en/glossary/hypergammaglobulinemia2024-07-03T02:18Zyearly https://clinicalinfo.hiv.gov/en/glossary/hyperglycemia2024-02-05T18:37Znever https://clinicalinfo.hiv.gov/en/glossary/hyperplasia2024-02-05T22:05Znever https://clinicalinfo.hiv.gov/en/glossary/hypogammaglobulinemia2024-07-03T02:20Zyearly https://clinicalinfo.hiv.gov/en/glossary/hypogonadism2024-07-03T02:21Zyearly https://clinicalinfo.hiv.gov/en/glossary/hypoxia2024-02-03T15:22Znever https://clinicalinfo.hiv.gov/en/glossary/idiopathic2024-02-05T18:50Znever https://clinicalinfo.hiv.gov/en/glossary/immune-thrombocytopenia-itp2024-02-01T18:56Znever https://clinicalinfo.hiv.gov/en/glossary/immune-complex2024-02-01T18:40Znever https://clinicalinfo.hiv.gov/en/glossary/immune-response2024-02-13T01:11Znever https://clinicalinfo.hiv.gov/en/glossary/immune-system2024-07-03T02:25Zyearly https://clinicalinfo.hiv.gov/en/glossary/immunity2024-02-01T16:56Znever https://clinicalinfo.hiv.gov/en/glossary/immunocompetent2024-02-05T19:03Znever https://clinicalinfo.hiv.gov/en/glossary/immunocompromised2024-02-13T01:13Znever https://clinicalinfo.hiv.gov/en/glossary/immunodeficiency2024-02-05T19:03Znever https://clinicalinfo.hiv.gov/en/glossary/immunogenicity2024-02-05T19:04Znever https://clinicalinfo.hiv.gov/en/glossary/immune-modulators2024-07-03T02:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/immunosuppression2024-02-05T19:04Znever https://clinicalinfo.hiv.gov/en/glossary/immunotherapy2024-02-05T19:05Znever https://clinicalinfo.hiv.gov/en/glossary/vitro2024-02-12T14:08Znever https://clinicalinfo.hiv.gov/en/glossary/vivo2024-02-12T14:08Znever https://clinicalinfo.hiv.gov/en/glossary/incidence2024-02-05T18:53Znever https://clinicalinfo.hiv.gov/en/glossary/eligibility-criteria2024-07-02T03:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/incubation-period2024-02-13T01:17Znever https://clinicalinfo.hiv.gov/en/glossary/indian-health-service-ihs2024-02-13T01:18Znever https://clinicalinfo.hiv.gov/en/glossary/infection2024-02-05T18:55Znever https://clinicalinfo.hiv.gov/en/glossary/infectious2024-02-05T18:54Znever https://clinicalinfo.hiv.gov/en/glossary/informed-consent2024-02-13T01:19Znever https://clinicalinfo.hiv.gov/en/glossary/infusion2024-02-05T19:01Znever https://clinicalinfo.hiv.gov/en/glossary/institutional-review-board-irb2024-07-03T02:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/integrase2024-02-01T16:58Znever https://clinicalinfo.hiv.gov/en/glossary/integrase-strand-transfer-inhibitor-insti2024-02-01T16:59Znever https://clinicalinfo.hiv.gov/en/glossary/integration2024-02-01T16:59Znever https://clinicalinfo.hiv.gov/en/glossary/interferon-ifn2024-02-05T19:09Znever https://clinicalinfo.hiv.gov/en/glossary/interleukin-2-il-22024-02-05T19:09Znever https://clinicalinfo.hiv.gov/en/glossary/interstitial-nephritis2024-02-05T22:18Znever https://clinicalinfo.hiv.gov/en/glossary/intramuscular-im2024-02-05T19:11Znever https://clinicalinfo.hiv.gov/en/glossary/intrapartum2024-02-01T17:00Znever https://clinicalinfo.hiv.gov/en/glossary/intravenous-iv2024-02-05T19:12Znever https://clinicalinfo.hiv.gov/en/glossary/intravenous-immunoglobulin-ivig2024-07-03T02:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/investigational-new-drug-ind-application2025-04-28T18:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/jaundice2024-02-05T18:50Znever https://clinicalinfo.hiv.gov/en/glossary/kaposi-sarcoma-ks2024-02-13T01:31Znever https://clinicalinfo.hiv.gov/en/glossary/karnofsky-performance-status-kps2024-02-13T01:32Znever https://clinicalinfo.hiv.gov/en/glossary/viral-latency2024-10-29T03:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/lentivirus2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/lesion2024-02-05T19:18Znever https://clinicalinfo.hiv.gov/en/glossary/leukocytosis2024-02-05T19:20Znever https://clinicalinfo.hiv.gov/en/glossary/lipid2024-02-05T19:26Znever https://clinicalinfo.hiv.gov/en/glossary/lipodystrophy-syndrome2025-04-28T18:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/log102024-07-03T03:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/long-term-nonprogressors-ltnp2024-10-24T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/lymph2024-02-05T19:20Znever https://clinicalinfo.hiv.gov/en/glossary/lymph-nodes2024-02-13T01:39Znever https://clinicalinfo.hiv.gov/en/glossary/lymphocyte2024-02-05T19:22Znever https://clinicalinfo.hiv.gov/en/glossary/lymphoid-interstitial-pneumonitis-lip2024-07-03T21:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/lymphoma2024-02-05T19:23Znever https://clinicalinfo.hiv.gov/en/glossary/lymphoproliferative-response2024-02-13T01:44Znever https://clinicalinfo.hiv.gov/en/glossary/lysis2024-02-05T19:25Znever https://clinicalinfo.hiv.gov/en/glossary/macrophage2024-02-05T19:27Znever https://clinicalinfo.hiv.gov/en/glossary/maintenance-therapy2024-07-03T21:33Zyearly https://clinicalinfo.hiv.gov/en/glossary/malabsorption-syndrome2024-02-13T01:48Znever https://clinicalinfo.hiv.gov/en/glossary/malaise2024-02-13T01:48Znever https://clinicalinfo.hiv.gov/en/glossary/malignant2024-02-13T01:49Znever https://clinicalinfo.hiv.gov/en/glossary/medlineplus2024-10-25T03:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/meningitis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/messenger-rna-mrna2024-02-13T01:52Znever https://clinicalinfo.hiv.gov/en/glossary/metabolism2024-02-05T19:27Znever https://clinicalinfo.hiv.gov/en/glossary/microorganism2024-02-05T22:10Znever https://clinicalinfo.hiv.gov/en/glossary/microbicide2024-07-03T21:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/microsporidiosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/mitochondria2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/mitochondrial-toxicity2024-02-13T01:55Znever https://clinicalinfo.hiv.gov/en/glossary/molluscum-contagiosum2024-02-05T22:07Znever https://clinicalinfo.hiv.gov/en/glossary/morbidity2024-02-05T22:07Znever https://clinicalinfo.hiv.gov/en/glossary/mucocutaneous2024-02-05T22:11Znever https://clinicalinfo.hiv.gov/en/glossary/multidrug-resistant-tuberculosis-mdr-tb2024-07-29T17:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/mutation2024-02-05T22:17Znever https://clinicalinfo.hiv.gov/en/glossary/myalgia2025-05-01T19:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/mycobacterium-avium-complex-mac-infection2025-04-29T19:36Zyearly https://clinicalinfo.hiv.gov/en/glossary/mycosis2024-02-13T01:54Znever https://clinicalinfo.hiv.gov/en/glossary/myelosuppression2024-02-01T19:09Znever https://clinicalinfo.hiv.gov/en/glossary/myopathy2024-02-05T19:28Znever https://clinicalinfo.hiv.gov/en/glossary/nadir2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/national-institute-allergy-and-infectious-diseases-niaid2024-10-25T03:18Zyearly https://clinicalinfo.hiv.gov/en/glossary/national-institutes-health-nih2024-10-25T03:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/national-library-medicine-nlm2024-07-03T22:10Zyearly https://clinicalinfo.hiv.gov/en/glossary/centers-disease-control-and-prevention-national-prevention-information-network-cdc-npin2024-06-29T01:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/natural-history-study2024-07-03T22:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/natural-killer-nk-cell2024-02-05T19:21Znever https://clinicalinfo.hiv.gov/en/glossary/neonatal2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/neoplasm2024-02-13T02:11Znever https://clinicalinfo.hiv.gov/en/glossary/nephrotoxic2024-02-05T22:19Znever https://clinicalinfo.hiv.gov/en/glossary/neuralgia2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/neuropathy2024-07-04T01:18Zyearly https://clinicalinfo.hiv.gov/en/glossary/neutropenia2024-07-04T01:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/neutrophil2024-02-05T22:20Znever https://clinicalinfo.hiv.gov/en/glossary/new-drug-application-nda2024-07-04T01:20Zyearly https://clinicalinfo.hiv.gov/en/glossary/non-hodgkin-lymphoma-nhl2024-07-29T17:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/non-nucleoside-reverse-transcriptase-inhibitor-nnrti2024-08-17T01:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/nonsteroidal-anti-inflammatory-drug-nsaid2024-07-04T01:28Zyearly https://clinicalinfo.hiv.gov/en/glossary/nucleic-acid2024-02-13T02:18Znever https://clinicalinfo.hiv.gov/en/glossary/nucleic-acid-test-nat2024-02-13T02:18Znever https://clinicalinfo.hiv.gov/en/glossary/nucleoside2024-02-05T22:21Znever https://clinicalinfo.hiv.gov/en/glossary/nucleotide2024-02-05T22:21Znever https://clinicalinfo.hiv.gov/en/glossary/nucleus2024-02-05T22:21Znever https://clinicalinfo.hiv.gov/en/glossary/office-aids-research-oar2024-07-04T01:37Zyearly https://clinicalinfo.hiv.gov/en/glossary/open-label-trial2024-10-29T02:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/opportunistic-infection-oi2024-02-02T18:52Znever https://clinicalinfo.hiv.gov/en/glossary/oral-hairy-leukoplakia-ohl2024-02-13T01:36Znever https://clinicalinfo.hiv.gov/en/glossary/osteonecrosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/osteopenia2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/p242024-11-15T21:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/palliative-care2024-07-04T01:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/pancreas2024-02-13T02:26Znever https://clinicalinfo.hiv.gov/en/glossary/pancreatitis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/pancytopenia2024-02-13T02:26Znever https://clinicalinfo.hiv.gov/en/glossary/pandemic2024-02-13T02:27Znever https://clinicalinfo.hiv.gov/en/glossary/pap-smear2024-07-04T01:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/papilloma2024-02-13T02:28Znever https://clinicalinfo.hiv.gov/en/glossary/parasite2024-07-04T01:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/parenteral2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/paresthesia2024-07-04T01:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/passive-immunity2025-04-09T19:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/passive-immunotherapy2024-07-04T01:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/pathogen2024-02-13T02:55Znever https://clinicalinfo.hiv.gov/en/glossary/pathogenesis2024-02-13T02:56Znever https://clinicalinfo.hiv.gov/en/glossary/pediatric-aids-clinical-trials-group-pactg2024-07-04T01:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/pelvic-inflammatory-disease-pid2024-07-04T01:59Zyearly https://clinicalinfo.hiv.gov/en/glossary/peptide2024-02-13T03:00Znever https://clinicalinfo.hiv.gov/en/glossary/perianal2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/perinatal2025-04-09T19:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/peripheral-neuropathy2024-02-05T22:20Znever https://clinicalinfo.hiv.gov/en/glossary/persistent-generalized-lymphadenopathy-pgl2024-07-06T02:00Zyearly https://clinicalinfo.hiv.gov/en/glossary/phase-1-trial2024-02-01T17:09Znever https://clinicalinfo.hiv.gov/en/glossary/phase-2-trial2024-02-01T17:09Znever https://clinicalinfo.hiv.gov/en/glossary/phase-3-trial2024-07-06T02:01Zyearly https://clinicalinfo.hiv.gov/en/glossary/phase-4-trial2024-07-06T02:02Zyearly https://clinicalinfo.hiv.gov/en/glossary/phenotypic-antiretroviral-resistance-test2024-02-13T03:03Znever https://clinicalinfo.hiv.gov/en/glossary/plasma2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/platelet2024-02-13T03:07Znever https://clinicalinfo.hiv.gov/en/glossary/pneumocystis-jirovecii-pneumonia-pjp2025-04-28T18:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/polymerase-chain-reaction-pcr2024-02-08T21:57Znever https://clinicalinfo.hiv.gov/en/glossary/polyneuritis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/polyvalent-vaccine2024-02-13T03:09Znever https://clinicalinfo.hiv.gov/en/glossary/postexposure-prophylaxis-pep2024-07-06T02:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/preclinical2024-02-01T17:10Znever https://clinicalinfo.hiv.gov/en/glossary/preconception-counseling-and-care2024-07-06T02:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/prevalence2024-02-14T20:00Znever https://clinicalinfo.hiv.gov/en/glossary/proctitis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/prophylaxis2024-02-14T20:38Znever https://clinicalinfo.hiv.gov/en/glossary/protease2024-02-01T17:11Znever https://clinicalinfo.hiv.gov/en/glossary/protease-inhibitor-pi2024-02-01T17:11Znever https://clinicalinfo.hiv.gov/en/glossary/pi-sparing-regimen2024-10-29T02:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/protein2024-02-08T21:54Znever https://clinicalinfo.hiv.gov/en/glossary/protocol2024-02-14T21:31Znever https://clinicalinfo.hiv.gov/en/glossary/protozoan2024-07-06T02:34Zyearly https://clinicalinfo.hiv.gov/en/glossary/provirus2021-06-03T19:04Znever https://clinicalinfo.hiv.gov/en/glossary/pruritus2024-02-14T21:32Znever https://clinicalinfo.hiv.gov/en/glossary/pubmed2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/pulmonary2024-02-14T21:33Znever https://clinicalinfo.hiv.gov/en/glossary/tuberculin-skin-test2024-07-09T01:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/people-hiv2025-04-28T18:52Zyearly https://clinicalinfo.hiv.gov/en/glossary/randomized-trial2024-07-06T02:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/receptor2024-02-01T18:08Znever https://clinicalinfo.hiv.gov/en/glossary/recombinant2024-02-01T18:08Znever https://clinicalinfo.hiv.gov/en/glossary/refractory2024-07-06T02:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/remission2024-02-01T18:15Znever https://clinicalinfo.hiv.gov/en/glossary/renal2024-02-01T18:15Znever https://clinicalinfo.hiv.gov/en/glossary/resistance-testing2024-02-01T18:19Znever https://clinicalinfo.hiv.gov/en/glossary/retinal-detachment2024-02-01T18:20Znever https://clinicalinfo.hiv.gov/en/glossary/retinitis2024-02-01T18:20Znever https://clinicalinfo.hiv.gov/en/glossary/retrovirus2024-02-01T18:21Znever https://clinicalinfo.hiv.gov/en/glossary/reverse-transcriptase-rt2024-02-01T18:26Znever https://clinicalinfo.hiv.gov/en/glossary/ribonucleic-acid-rna2024-02-01T18:27Znever https://clinicalinfo.hiv.gov/en/glossary/ryan-white-hivaids-program2024-07-06T02:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/salmonella-septicemia2024-02-12T14:09Znever https://clinicalinfo.hiv.gov/en/glossary/salvage-therapy2024-02-01T18:18Znever https://clinicalinfo.hiv.gov/en/glossary/seborrheic-dermatitis2024-07-06T02:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/sepsis2024-02-01T22:09Znever https://clinicalinfo.hiv.gov/en/glossary/seroconversion2024-10-26T03:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/serologic-test2024-02-01T22:24Znever https://clinicalinfo.hiv.gov/en/glossary/seroprevalence2024-02-01T22:24Znever https://clinicalinfo.hiv.gov/en/glossary/serum2024-02-01T22:25Znever https://clinicalinfo.hiv.gov/en/glossary/set-point2024-10-26T03:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/sexually-transmitted-disease-std2024-07-02T00:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/shingles2024-07-06T03:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/simian-immunodeficiency-virus-siv2024-02-01T22:29Znever https://clinicalinfo.hiv.gov/en/glossary/spinal-tap2024-02-01T22:31Znever https://clinicalinfo.hiv.gov/en/glossary/splenomegaly2024-02-01T22:31Znever https://clinicalinfo.hiv.gov/en/glossary/sputum-analysis2024-02-01T22:32Znever https://clinicalinfo.hiv.gov/en/glossary/standard-care2024-08-17T02:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/stem-cells2024-02-01T22:33Znever https://clinicalinfo.hiv.gov/en/glossary/stomatitis2024-02-01T22:36Znever https://clinicalinfo.hiv.gov/en/glossary/subclinical-infection2024-02-01T22:39Znever https://clinicalinfo.hiv.gov/en/glossary/subcutaneous-sc-sub-q2024-02-01T22:40Znever https://clinicalinfo.hiv.gov/en/glossary/substance-abuse-and-mental-health-services-administration-samhsa2024-07-06T03:28Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-susceptible-hiv2024-08-08T20:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/syncytium2024-07-06T03:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/syndrome2024-02-01T22:44Znever https://clinicalinfo.hiv.gov/en/glossary/syphilis2025-04-09T19:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/systemic2024-02-01T22:45Znever https://clinicalinfo.hiv.gov/en/glossary/t-lymphocyte2024-10-29T03:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/lymphocyte-proliferation-assay2024-02-13T01:41Znever https://clinicalinfo.hiv.gov/en/glossary/sexual-maturity-rating-smr2024-07-06T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/testosterone2024-02-01T19:35Znever https://clinicalinfo.hiv.gov/en/glossary/therapeutic-hiv-vaccine2024-07-06T03:36Zyearly https://clinicalinfo.hiv.gov/en/glossary/thrombocytopenia2024-02-01T19:38Znever https://clinicalinfo.hiv.gov/en/glossary/thymus2024-02-01T19:38Znever https://clinicalinfo.hiv.gov/en/glossary/titer2024-02-01T19:38Znever https://clinicalinfo.hiv.gov/en/glossary/toxicity2024-02-01T19:43Znever https://clinicalinfo.hiv.gov/en/glossary/toxoplasmosis2025-04-09T19:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/transplacental2025-04-09T19:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/triglycerides2024-02-01T19:48Znever https://clinicalinfo.hiv.gov/en/glossary/tuberculosis-tb2024-10-26T03:36Zyearly https://clinicalinfo.hiv.gov/en/glossary/vaccination2024-02-01T18:40Znever https://clinicalinfo.hiv.gov/en/glossary/vaccine2024-07-09T01:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/varicella-zoster-virus-vzv2024-02-01T18:42Znever https://clinicalinfo.hiv.gov/en/glossary/vector2024-02-01T18:48Znever https://clinicalinfo.hiv.gov/en/glossary/viral-load-test2025-04-28T19:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/viremia2024-02-01T19:22Znever https://clinicalinfo.hiv.gov/en/glossary/viricide2024-02-01T19:23Znever https://clinicalinfo.hiv.gov/en/glossary/virology2024-02-01T19:23Znever https://clinicalinfo.hiv.gov/en/glossary/virus2024-07-09T02:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/wasting-syndrome2024-07-09T02:28Zyearly https://clinicalinfo.hiv.gov/en/glossary/western-blot2024-10-26T03:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/white-blood-cell2024-02-01T18:32Znever https://clinicalinfo.hiv.gov/en/glossary/wild-type-virus2024-10-26T03:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/womens-interagency-hiv-study-wihs2024-07-09T02:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/prenatal2024-02-01T18:37Znever https://clinicalinfo.hiv.gov/en/glossary/drug-synergism2024-02-01T22:44Znever https://clinicalinfo.hiv.gov/en/glossary/hypersensitivity-syndrome2025-04-28T18:28Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-antagonism2024-02-01T21:07Znever https://clinicalinfo.hiv.gov/en/glossary/drug-interaction2024-02-01T21:09Znever https://clinicalinfo.hiv.gov/en/glossary/dual-energy-x-ray-absorptiometry-dxa-dexa2024-02-01T19:07Znever https://clinicalinfo.hiv.gov/en/glossary/dyslipidemia2024-02-13T00:31Znever https://clinicalinfo.hiv.gov/en/glossary/eosinophilia2024-02-01T21:20Znever https://clinicalinfo.hiv.gov/en/glossary/fixed-dose-combination-fdc2024-08-08T20:27Zyearly https://clinicalinfo.hiv.gov/en/glossary/hepatic-necrosis2024-02-05T22:18Znever https://clinicalinfo.hiv.gov/en/glossary/hepatic-steatosis2024-02-01T20:34Znever https://clinicalinfo.hiv.gov/en/glossary/hepatitis2021-06-02T18:56Znever https://clinicalinfo.hiv.gov/en/glossary/hepatitis-b-virus-infection-hbv2024-02-05T18:56Znever https://clinicalinfo.hiv.gov/en/glossary/hepatitis-c-virus-infection-hcv2024-02-05T18:56Znever https://clinicalinfo.hiv.gov/en/glossary/hepatotoxicity2024-02-05T22:04Znever https://clinicalinfo.hiv.gov/en/glossary/adherence2024-02-05T16:33Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-prevention-trials-network-hptn2024-08-15T02:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/aids-defining-condition2024-08-09T18:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/hyperlipidemia2024-07-03T02:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/immune-reconstitution-inflammatory-syndrome-iris2024-07-03T02:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/antepartum2024-02-01T18:38Znever https://clinicalinfo.hiv.gov/en/glossary/suboptimal-immunologic-response2024-02-01T22:40Znever https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-arv2024-02-01T18:47Znever https://clinicalinfo.hiv.gov/en/glossary/insulin-resistance2024-02-13T01:21Znever https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-pregnancy-registry2024-02-01T18:47Znever https://clinicalinfo.hiv.gov/en/glossary/intravaginal2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/area-under-curve-auc2024-02-05T22:26Znever https://clinicalinfo.hiv.gov/en/glossary/lactic-acidosis2024-07-03T02:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/lipid-profile2024-10-29T02:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/lipoatrophy2024-07-03T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/lipohypertrophy2024-07-03T03:06Zyearly https://clinicalinfo.hiv.gov/en/glossary/liver-function-test2024-02-13T01:38Znever https://clinicalinfo.hiv.gov/en/glossary/boxed-warning2024-06-29T01:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/medication-event-monitoring-system-mems2024-02-13T01:51Znever https://clinicalinfo.hiv.gov/en/glossary/body-habitus-changes2024-06-29T01:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/mortality2024-02-05T22:11Znever https://clinicalinfo.hiv.gov/en/glossary/perinatal-transmission2025-04-09T19:34Zyearly https://clinicalinfo.hiv.gov/en/glossary/nephritis2024-02-05T22:18Znever https://clinicalinfo.hiv.gov/en/glossary/label-use2024-10-29T02:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/budding2024-02-05T18:30Znever https://clinicalinfo.hiv.gov/en/glossary/osteoporosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/package-insert2024-07-04T01:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/peripheral-blood-mononuclear-cell-pbmc2024-02-05T22:07Znever https://clinicalinfo.hiv.gov/en/glossary/pharmacokinetics2024-02-01T17:09Znever https://clinicalinfo.hiv.gov/en/glossary/pharmacology2024-02-13T03:03Znever https://clinicalinfo.hiv.gov/en/glossary/cardiomyopathy2024-06-29T01:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-count2024-08-13T03:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-percentage2024-08-13T03:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-receptor2024-08-13T03:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/cholesterol2024-02-01T19:54Znever https://clinicalinfo.hiv.gov/en/glossary/class-sparing-regimen2024-07-29T20:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/coinfection2024-07-02T02:29Zyearly https://clinicalinfo.hiv.gov/en/glossary/comorbidity2024-02-01T20:14Znever https://clinicalinfo.hiv.gov/en/glossary/expanded-access2024-10-24T02:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/cytochrome-p450-cyp4502024-02-01T20:29Znever https://clinicalinfo.hiv.gov/en/glossary/directly-observed-therapy-dot2024-02-01T21:03Znever https://clinicalinfo.hiv.gov/en/glossary/bid2024-08-13T03:20Zyearly https://clinicalinfo.hiv.gov/en/glossary/quantitative-branched-dna-assay-bdna2024-07-06T02:37Zyearly https://clinicalinfo.hiv.gov/en/glossary/clinical-endpoint2024-02-01T20:01Znever https://clinicalinfo.hiv.gov/en/glossary/cmax2024-02-13T01:29Znever https://clinicalinfo.hiv.gov/en/glossary/cmin2024-02-13T01:30Znever https://clinicalinfo.hiv.gov/en/glossary/dorsocervical-fat-pad2024-02-01T19:13Znever https://clinicalinfo.hiv.gov/en/glossary/photosensitivity2024-02-13T03:05Znever https://clinicalinfo.hiv.gov/en/glossary/pill-burden2024-02-13T03:05Znever https://clinicalinfo.hiv.gov/en/glossary/placebo2024-02-01T22:28Znever https://clinicalinfo.hiv.gov/en/glossary/placebo-controlled-trial2024-10-29T02:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/placebo-effect2024-10-29T02:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/postnatal2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/postpartum2024-02-01T17:10Znever https://clinicalinfo.hiv.gov/en/glossary/preventive-hiv-vaccine2024-10-25T03:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/progressive-multifocal-leukoencephalopathy-pml2024-02-05T19:19Znever https://clinicalinfo.hiv.gov/en/glossary/qd2024-02-01T17:43Znever https://clinicalinfo.hiv.gov/en/glossary/qid2024-02-01T17:45Znever https://clinicalinfo.hiv.gov/en/glossary/statin2024-02-01T22:33Znever https://clinicalinfo.hiv.gov/en/glossary/stevens-johnson-syndrome-sjs2024-02-01T22:35Znever https://clinicalinfo.hiv.gov/en/glossary/subcutaneous-adipose-tissue-sat2024-07-06T03:27Zyearly https://clinicalinfo.hiv.gov/en/glossary/superinfection2024-02-01T22:42Znever https://clinicalinfo.hiv.gov/en/glossary/therapeutic-drug-monitoring-tdm2024-02-01T19:36Znever https://clinicalinfo.hiv.gov/en/glossary/therapeutic-index-ti2024-02-01T19:37Znever https://clinicalinfo.hiv.gov/en/glossary/tid2024-10-29T03:08Zyearly https://clinicalinfo.hiv.gov/en/glossary/tolerance2024-02-01T19:39Znever https://clinicalinfo.hiv.gov/en/glossary/toxic-epidermal-necrolysis-ten2024-07-06T03:37Zyearly https://clinicalinfo.hiv.gov/en/glossary/treatment-experienced2024-10-29T03:09Zyearly https://clinicalinfo.hiv.gov/en/glossary/treatment-failure2024-08-17T03:10Zyearly https://clinicalinfo.hiv.gov/en/glossary/treatment-naive2024-10-29T03:09Zyearly https://clinicalinfo.hiv.gov/en/glossary/undetectable-viral-load2026-05-07T15:35Zmonthly https://clinicalinfo.hiv.gov/en/glossary/viral-load-vl2024-10-29T03:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/viral-rebound2024-10-29T03:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/virologic-failure2024-02-01T18:39Znever https://clinicalinfo.hiv.gov/en/glossary/visceral-adipose-tissue-vat2024-07-09T02:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/window-period2024-07-09T02:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/x4-tropic-virus2024-10-29T03:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-therapy-art2026-05-07T13:44Zmonthly https://clinicalinfo.hiv.gov/en/glossary/magnetic-resonance-imaging-mri2024-10-25T03:05Zyearly https://clinicalinfo.hiv.gov/en/glossary/subtype2024-02-01T19:59Znever https://clinicalinfo.hiv.gov/en/glossary/cd8-t-lymphocyte2024-08-13T03:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/cross-sensitivity2024-08-13T04:02Zyearly https://clinicalinfo.hiv.gov/en/glossary/secondary-transmission2025-04-09T19:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/kaposi-sarcoma-associated-herpesvirus-kshv2024-07-29T16:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/national-cancer-institute-nci2024-10-25T03:20Zyearly https://clinicalinfo.hiv.gov/en/glossary/rapid-test2024-07-06T02:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/reverse-transcriptase-polymerase-chain-reaction-based-assay-rt-pcr2025-04-28T19:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/multicenter-aids-cohort-study-macs2024-07-03T21:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/interleukin-7-il-72024-02-05T19:10Znever https://clinicalinfo.hiv.gov/en/glossary/nucleoside-reverse-transcriptase-inhibitor-nrti2024-02-01T17:06Znever https://clinicalinfo.hiv.gov/en/glossary/nucleotide-reverse-transcriptase-inhibitor-ntrti2024-02-01T17:07Znever https://clinicalinfo.hiv.gov/en/glossary/formulation2024-02-14T16:03Znever https://clinicalinfo.hiv.gov/en/glossary/metabolic-syndrome2024-02-01T22:44Znever https://clinicalinfo.hiv.gov/en/glossary/lymphogranuloma-venereum-lgv2024-07-03T21:29Zyearly https://clinicalinfo.hiv.gov/en/glossary/investigational-drug2024-07-03T02:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/cdc-info2024-08-13T03:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/clinicalinfo2024-07-25T19:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/cystoisosporiasis2024-07-02T02:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/utero2024-02-12T14:08Znever https://clinicalinfo.hiv.gov/en/glossary/clinicalinfo-es2024-07-02T02:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/mycobacterium-tuberculosis2025-04-28T19:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/adenovirus2024-02-01T18:31Znever https://clinicalinfo.hiv.gov/en/glossary/adverse-event-ae2026-04-21T21:56Zmonthly https://clinicalinfo.hiv.gov/en/glossary/aids-clinical-trials-group-actg2024-08-09T18:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/atherosclerosis2024-02-01T18:54Znever https://clinicalinfo.hiv.gov/en/glossary/ccr5-antagonist2024-08-09T19:27Zyearly https://clinicalinfo.hiv.gov/en/glossary/chemoprevention2024-02-01T19:52Znever https://clinicalinfo.hiv.gov/en/glossary/clinical-progression2024-02-01T20:02Znever https://clinicalinfo.hiv.gov/en/glossary/drug-concentration2024-02-01T20:17Znever https://clinicalinfo.hiv.gov/en/glossary/dendritic-cell-vaccine2024-02-01T21:00Znever https://clinicalinfo.hiv.gov/en/glossary/disseminated2024-02-01T21:03Znever https://clinicalinfo.hiv.gov/en/glossary/dosage2024-02-01T21:05Znever https://clinicalinfo.hiv.gov/en/glossary/dose2024-02-01T21:06Znever https://clinicalinfo.hiv.gov/en/glossary/dose-ranging-trial2024-08-06T19:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-class2024-07-02T02:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/eradication2024-02-01T21:23Znever https://clinicalinfo.hiv.gov/en/glossary/extensively-drug-resistant-tuberculosis-xdr-tb2024-07-02T03:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/false-negative2024-02-01T20:33Znever https://clinicalinfo.hiv.gov/en/glossary/false-positive2024-02-01T20:33Znever https://clinicalinfo.hiv.gov/en/glossary/fanconi-syndrome2024-02-01T20:34Znever https://clinicalinfo.hiv.gov/en/glossary/first-line-therapy2024-08-08T20:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/generic-drug2024-02-01T21:45Znever https://clinicalinfo.hiv.gov/en/glossary/guillain-barre-syndrome-gbs2024-08-15T02:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/hypersensitivity2024-02-05T18:37Znever https://clinicalinfo.hiv.gov/en/glossary/hypertension2024-02-05T18:33Znever https://clinicalinfo.hiv.gov/en/glossary/hypertriglyceridemia2024-02-05T18:33Znever https://clinicalinfo.hiv.gov/en/glossary/immunologic2024-02-05T19:02Znever https://clinicalinfo.hiv.gov/en/glossary/injection-drug-use2024-02-13T01:20Znever https://clinicalinfo.hiv.gov/en/glossary/injection-site-reaction2024-02-08T21:56Znever https://clinicalinfo.hiv.gov/en/glossary/insulin2024-02-05T19:08Znever https://clinicalinfo.hiv.gov/en/glossary/insulin-sensitivity2024-02-13T01:22Znever https://clinicalinfo.hiv.gov/en/glossary/international-maternal-pediatric-adolescent-aids-clinical-trials-impaact-group2025-04-09T19:33Zyearly https://clinicalinfo.hiv.gov/en/glossary/international-network-strategic-initiatives-global-hiv-trials-insight2024-07-03T02:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/intervention2024-02-05T19:10Znever https://clinicalinfo.hiv.gov/en/glossary/latent-hiv-reservoir2024-07-03T02:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/leukopenia2024-02-05T19:20Znever https://clinicalinfo.hiv.gov/en/glossary/life-cycle2024-02-01T18:16Znever https://clinicalinfo.hiv.gov/en/glossary/linear-gingival-erythema-lge2024-07-03T03:02Zyearly https://clinicalinfo.hiv.gov/en/glossary/localized2024-02-05T19:26Znever https://clinicalinfo.hiv.gov/en/glossary/lymphopenia2024-02-05T19:24Znever https://clinicalinfo.hiv.gov/en/glossary/malaria2024-07-03T21:35Zyearly https://clinicalinfo.hiv.gov/en/glossary/mast-cell2024-02-13T01:50Znever https://clinicalinfo.hiv.gov/en/glossary/metabolic2024-02-05T19:27Znever https://clinicalinfo.hiv.gov/en/glossary/microbicide-trials-network-mtn2024-07-03T21:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/monotherapy2024-02-13T01:59Znever https://clinicalinfo.hiv.gov/en/glossary/msm2024-08-08T21:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/nemaline-rod-myopathy-nm2024-07-04T01:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/nnrti-sparing-regimen2024-08-08T21:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/nrti-sparing-regimen2024-08-08T21:56Zyearly https://clinicalinfo.hiv.gov/en/glossary/occupational-exposure2024-02-13T02:20Znever https://clinicalinfo.hiv.gov/en/glossary/optimized-background-therapy-obt2024-07-04T01:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/pre-exposure-prophylaxis-prep2024-10-25T03:29Zyearly https://clinicalinfo.hiv.gov/en/glossary/presidents-emergency-plan-aids-relief-pepfar2024-07-06T02:20Zyearly https://clinicalinfo.hiv.gov/en/glossary/prevention-perinatal-transmission2025-04-09T19:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/primary-prophylaxis2024-07-06T02:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/transmitted-resistance2024-02-01T19:45Znever https://clinicalinfo.hiv.gov/en/glossary/r5-tropic-virus2024-07-29T17:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/relapse2024-02-01T18:14Znever https://clinicalinfo.hiv.gov/en/glossary/self-administered-therapy-sat2024-02-01T22:08Znever https://clinicalinfo.hiv.gov/en/glossary/serostatus2024-02-01T22:25Znever https://clinicalinfo.hiv.gov/en/glossary/strain2024-02-01T22:36Znever https://clinicalinfo.hiv.gov/en/glossary/surrogate-endpoint2024-02-01T22:43Znever https://clinicalinfo.hiv.gov/en/glossary/t-cell-exhaustion2024-07-29T18:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/topical2024-02-01T19:39Znever https://clinicalinfo.hiv.gov/en/glossary/treatment-regimen2024-08-17T03:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/triple-class-experienced2024-02-01T19:48Znever https://clinicalinfo.hiv.gov/en/glossary/viral-evolution2024-10-29T03:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/replication2024-02-01T18:16Znever https://clinicalinfo.hiv.gov/en/glossary/viral-suppression2026-05-07T15:36Zmonthly https://clinicalinfo.hiv.gov/en/glossary/viral-tropism2024-10-29T03:17Zyearly https://clinicalinfo.hiv.gov/en/glossary/world-health-organization-who2024-02-01T18:34Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-22025-02-10T17:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/structured-treatment-interruption2024-02-01T21:09Znever https://clinicalinfo.hiv.gov/en/glossary/acquired-resistance2024-06-28T21:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/adenopathy2024-02-01T18:31Znever https://clinicalinfo.hiv.gov/en/glossary/aids-case-definition2024-08-06T19:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/lymphadenopathy2024-02-13T01:40Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-associated-neurocognitive-disorders-hand2024-08-15T02:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/chronic-hiv-infection2024-06-29T02:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/autoimmune-disorder2024-02-01T18:56Znever https://clinicalinfo.hiv.gov/en/glossary/comprehensive-metabolic-panel-cmp2024-02-01T20:16Znever https://clinicalinfo.hiv.gov/en/glossary/cesarean-delivery2025-04-09T18:22Zyearly https://clinicalinfo.hiv.gov/en/glossary/cesarean-section2024-02-01T19:18Znever https://clinicalinfo.hiv.gov/en/glossary/cardiovascular2024-02-01T19:47Znever https://clinicalinfo.hiv.gov/en/glossary/cyp3a42024-08-06T19:20Zyearly https://clinicalinfo.hiv.gov/en/glossary/end-stage-renal-disease-esrd2024-08-15T02:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/end-stage-liver-disease-esld2024-08-15T02:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/enteric-coated-ec2024-08-08T20:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/gastroenteritis2024-02-01T21:44Znever https://clinicalinfo.hiv.gov/en/glossary/depression2024-02-01T21:01Znever https://clinicalinfo.hiv.gov/en/glossary/conjunctivitis2024-02-01T18:11Znever https://clinicalinfo.hiv.gov/en/glossary/edema2024-02-01T21:12Znever https://clinicalinfo.hiv.gov/en/glossary/tachycardia2024-02-01T19:32Znever https://clinicalinfo.hiv.gov/en/glossary/tachypnea2024-02-01T19:32Znever https://clinicalinfo.hiv.gov/en/glossary/hematuria2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hemorrhage2024-02-13T00:49Znever https://clinicalinfo.hiv.gov/en/glossary/coagulopathy2024-02-01T20:05Znever https://clinicalinfo.hiv.gov/en/glossary/anticoagulant2024-02-01T18:39Znever https://clinicalinfo.hiv.gov/en/glossary/myocardial-infarction2024-02-05T18:54Znever https://clinicalinfo.hiv.gov/en/glossary/ischemia2024-02-13T01:27Znever https://clinicalinfo.hiv.gov/en/glossary/stroke2024-02-01T19:10Znever https://clinicalinfo.hiv.gov/en/glossary/arrhythmia2024-02-01T18:51Znever https://clinicalinfo.hiv.gov/en/glossary/bone-marrow2024-02-01T19:08Znever https://clinicalinfo.hiv.gov/en/glossary/sexual-transmission2024-07-06T03:05Zyearly https://clinicalinfo.hiv.gov/en/glossary/hla-b5701-test2024-10-29T02:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/dysplasia2024-02-13T00:32Znever https://clinicalinfo.hiv.gov/en/glossary/rhabdomyolysis2024-07-06T02:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/rechallenge2024-02-01T18:08Znever https://clinicalinfo.hiv.gov/en/glossary/asthenia2024-02-01T18:54Znever https://clinicalinfo.hiv.gov/en/glossary/bronchospasm2024-02-01T19:12Znever https://clinicalinfo.hiv.gov/en/glossary/urticaria2024-02-01T19:28Znever https://clinicalinfo.hiv.gov/en/glossary/elite-controllers2024-02-01T21:13Znever https://clinicalinfo.hiv.gov/en/glossary/lymphatic-system2024-02-13T01:41Znever https://clinicalinfo.hiv.gov/en/glossary/memory-lymphocyte2024-02-05T19:21Znever https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-toxic-neuropathy-atn2024-02-01T18:48Znever https://clinicalinfo.hiv.gov/en/glossary/mononeuropathy2024-02-05T22:07Znever https://clinicalinfo.hiv.gov/en/glossary/polyneuropathy2024-02-13T03:08Znever https://clinicalinfo.hiv.gov/en/glossary/mycobacterium-kansasii-infection2025-04-28T19:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/national-center-complementary-and-integrative-health-nccih2024-10-25T03:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/pneumonia2024-02-01T19:11Znever https://clinicalinfo.hiv.gov/en/glossary/retrospective-study2024-02-01T18:20Znever https://clinicalinfo.hiv.gov/en/glossary/salmonella2024-02-12T14:10Znever https://clinicalinfo.hiv.gov/en/glossary/spermicide2024-07-06T03:18Zyearly https://clinicalinfo.hiv.gov/en/glossary/spleen2024-02-01T22:31Znever https://clinicalinfo.hiv.gov/en/glossary/intradermal2024-02-05T19:11Znever https://clinicalinfo.hiv.gov/en/glossary/regulatory-t-lymphocyte2024-02-01T18:13Znever https://clinicalinfo.hiv.gov/en/glossary/tuberculosis-disease2024-07-09T01:36Zyearly https://clinicalinfo.hiv.gov/en/glossary/dual-tropic-virus2024-08-15T02:18Zyearly https://clinicalinfo.hiv.gov/en/glossary/sensitivity2024-02-01T22:09Znever https://clinicalinfo.hiv.gov/en/glossary/specificity2024-02-01T22:30Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-associated-nephropathy-hivan2024-08-15T02:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/proteinuria2024-02-01T18:34Znever https://clinicalinfo.hiv.gov/en/glossary/bartonellosis2024-02-01T19:01Znever https://clinicalinfo.hiv.gov/en/glossary/talaromyces-marneffei-infection2025-04-28T19:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/leishmaniasis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/chagas-disease2024-02-01T18:36Znever https://clinicalinfo.hiv.gov/en/glossary/campylobacteriosis2024-02-01T19:44Znever https://clinicalinfo.hiv.gov/en/glossary/shigellosis2024-02-01T22:28Znever https://clinicalinfo.hiv.gov/en/glossary/streptococcus-pneumoniae-infection2025-04-28T19:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/regimen-simplification2024-02-01T18:13Znever https://clinicalinfo.hiv.gov/en/glossary/qualitative-transcription-mediated-amplification-assay2024-07-29T17:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/rigors2024-02-01T18:28Znever https://clinicalinfo.hiv.gov/en/glossary/ecchymosis2024-02-01T21:11Znever https://clinicalinfo.hiv.gov/en/glossary/intrauterine-insemination-iui2024-02-01T18:52Znever https://clinicalinfo.hiv.gov/en/glossary/sperm-washing2024-07-06T03:17Zyearly https://clinicalinfo.hiv.gov/en/glossary/vitro-fertilization-ivf2024-02-13T01:16Znever https://clinicalinfo.hiv.gov/en/glossary/intracytoplasmic-sperm-injection-icsi2024-02-05T19:13Znever https://clinicalinfo.hiv.gov/en/glossary/kernicterus2024-02-01T21:25Znever https://clinicalinfo.hiv.gov/en/glossary/lipoma2024-07-03T03:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/cholangiopathy2024-02-01T19:54Znever https://clinicalinfo.hiv.gov/en/glossary/neuroaids2024-02-13T02:13Znever https://clinicalinfo.hiv.gov/en/glossary/vacuolar-myelopathy2024-07-09T01:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/myelin2024-02-05T19:28Znever https://clinicalinfo.hiv.gov/en/glossary/acanthosis-nigricans2024-02-01T18:28Znever https://clinicalinfo.hiv.gov/en/glossary/prodrome2024-02-14T20:37Znever https://clinicalinfo.hiv.gov/en/glossary/gynecomastia2024-02-01T21:52Znever https://clinicalinfo.hiv.gov/en/glossary/nephrolithiasis2024-02-05T22:19Znever https://clinicalinfo.hiv.gov/en/glossary/urolithiasis2024-02-01T19:28Znever https://clinicalinfo.hiv.gov/en/glossary/crystalluria2024-02-01T20:27Znever https://clinicalinfo.hiv.gov/en/glossary/retina2024-02-01T18:20Znever https://clinicalinfo.hiv.gov/en/glossary/urinalysis-ua2024-07-09T01:37Zyearly https://clinicalinfo.hiv.gov/en/glossary/office-minority-health-omh2024-07-04T01:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/nonoccupational-postexposure-prophylaxis-npep2024-07-04T01:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/occupational-postexposure-prophylaxis-opep2024-07-04T01:36Zyearly https://clinicalinfo.hiv.gov/en/glossary/clastogenic2024-02-01T20:00Znever https://clinicalinfo.hiv.gov/en/glossary/teratogenic2024-02-01T19:35Znever https://clinicalinfo.hiv.gov/en/glossary/mutagenic2024-07-03T21:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/fusion2024-02-05T18:29Znever https://clinicalinfo.hiv.gov/en/glossary/reverse-transcription2024-02-01T18:27Znever https://clinicalinfo.hiv.gov/en/glossary/peripheral-nervous-system-pns2024-02-13T03:02Znever https://clinicalinfo.hiv.gov/en/glossary/albumin2024-02-01T18:34Znever https://clinicalinfo.hiv.gov/en/glossary/gamma-glutamyl-transpeptidase-ggt2024-08-15T02:35Zyearly https://clinicalinfo.hiv.gov/en/glossary/aspartate-aminotransferase-ast2024-02-01T18:53Znever https://clinicalinfo.hiv.gov/en/glossary/alanine-aminotransferase-alt2024-02-01T18:33Znever https://clinicalinfo.hiv.gov/en/glossary/alkaline-phosphatase-alp2024-02-01T18:35Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-progression2024-10-24T03:06Zyearly https://clinicalinfo.hiv.gov/en/glossary/liver2024-07-03T03:08Zyearly https://clinicalinfo.hiv.gov/en/glossary/control-arm2024-02-01T20:19Znever https://clinicalinfo.hiv.gov/en/glossary/invasive2024-02-05T19:13Znever https://clinicalinfo.hiv.gov/en/glossary/kidneys2024-02-13T01:33Znever https://clinicalinfo.hiv.gov/en/glossary/chromosome2024-02-01T19:57Znever https://clinicalinfo.hiv.gov/en/glossary/interventional-trial2024-02-16T02:24Znever https://clinicalinfo.hiv.gov/en/glossary/observational-trial2024-02-13T02:20Znever https://clinicalinfo.hiv.gov/en/glossary/human-leukocyte-antigen-complex2024-02-03T14:54Znever https://clinicalinfo.hiv.gov/en/glossary/innate-immunity2024-02-05T19:02Znever https://clinicalinfo.hiv.gov/en/glossary/glucose2024-02-01T19:06Znever https://clinicalinfo.hiv.gov/en/glossary/lactic-acid2024-02-13T01:34Znever https://clinicalinfo.hiv.gov/en/glossary/semen2024-02-01T22:08Znever https://clinicalinfo.hiv.gov/en/glossary/msmw2024-08-08T21:52Zyearly https://clinicalinfo.hiv.gov/en/glossary/experimental-arm2024-02-01T21:26Znever https://clinicalinfo.hiv.gov/en/glossary/condom2024-07-02T02:34Zyearly https://clinicalinfo.hiv.gov/en/glossary/fetus2024-02-01T20:34Znever https://clinicalinfo.hiv.gov/en/glossary/latent-tuberculosis-infection-ltbi2024-07-03T02:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/true-positive2024-02-01T19:50Znever https://clinicalinfo.hiv.gov/en/glossary/true-negative2024-02-01T19:49Znever https://clinicalinfo.hiv.gov/en/glossary/embryo2024-02-01T21:13Znever https://clinicalinfo.hiv.gov/en/glossary/single-blind-study2024-02-01T22:30Znever https://clinicalinfo.hiv.gov/en/glossary/modified-directly-observed-therapy-m-dot2024-02-13T01:57Znever https://clinicalinfo.hiv.gov/en/glossary/host2024-02-05T18:35Znever https://clinicalinfo.hiv.gov/en/glossary/child-turcotte-pugh-classification-system2024-08-13T03:52Zyearly https://clinicalinfo.hiv.gov/en/glossary/alopecia2024-02-01T18:35Znever https://clinicalinfo.hiv.gov/en/glossary/circumoral2024-02-01T19:58Znever https://clinicalinfo.hiv.gov/en/glossary/replicate2024-02-01T18:16Znever https://clinicalinfo.hiv.gov/en/glossary/definitive2024-07-02T02:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/presumptive2025-02-13T20:00Zyearly https://clinicalinfo.hiv.gov/en/glossary/hyperuricemia2024-02-05T18:34Znever https://clinicalinfo.hiv.gov/en/glossary/quasispecies2024-07-06T02:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/monoinfection2024-02-05T22:06Znever https://clinicalinfo.hiv.gov/en/glossary/noninferiority-trial2024-07-04T01:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/superiority-trial2024-02-01T22:42Znever https://clinicalinfo.hiv.gov/en/glossary/relative-contraindication2024-02-01T18:14Znever https://clinicalinfo.hiv.gov/en/glossary/absolute-contraindication2024-02-01T18:27Znever https://clinicalinfo.hiv.gov/en/glossary/medline2024-08-08T21:51Zyearly https://clinicalinfo.hiv.gov/en/glossary/infectious-disease2024-02-13T01:19Znever https://clinicalinfo.hiv.gov/en/glossary/communicable-disease2024-02-01T20:08Znever https://clinicalinfo.hiv.gov/en/glossary/pediatric-aids-clinical-trials-group-076-pactg-0762024-07-04T01:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/placenta2024-07-06T02:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/dualmixed-tropic-virus2024-08-15T02:19Zyearly https://clinicalinfo.hiv.gov/en/glossary/entry-inhibitor2024-02-01T21:18Znever https://clinicalinfo.hiv.gov/en/glossary/antibody-differentiation-test2024-06-29T00:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/antigenantibody-combination-test2024-08-13T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/assembly2024-02-12T22:12Znever https://clinicalinfo.hiv.gov/en/glossary/backbone2024-02-05T16:27Znever https://clinicalinfo.hiv.gov/en/glossary/binding2024-02-12T22:24Znever https://clinicalinfo.hiv.gov/en/glossary/distal-sensory-polyneuropathy-dsp2024-07-02T02:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/mixed-tropic-hiv2024-02-13T01:56Znever https://clinicalinfo.hiv.gov/en/glossary/pharmacokinetic-enhancers2024-02-01T17:09Znever https://clinicalinfo.hiv.gov/en/glossary/transmission2026-05-07T15:35Zmonthly https://clinicalinfo.hiv.gov/en/glossary/rev-inhibitor2024-07-06T02:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/nonreactive-test-result2024-02-13T02:17Znever https://clinicalinfo.hiv.gov/en/glossary/reactive-test-result2024-02-01T17:54Znever https://clinicalinfo.hiv.gov/en/glossary/attachment-inhibitor2024-02-01T18:55Znever https://clinicalinfo.hiv.gov/en/glossary/biological-response-modifiers-brms2024-02-01T19:04Znever https://clinicalinfo.hiv.gov/en/glossary/broadly-neutralizing-antibodies-bnabs2024-02-01T19:10Znever https://clinicalinfo.hiv.gov/en/glossary/coronary-heart-disease-chd2024-07-02T02:36Zyearly https://clinicalinfo.hiv.gov/en/glossary/cxcr4-antagonist2024-08-13T03:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-continuum-care2024-08-15T02:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-navigation2024-08-15T02:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/navigator2024-02-05T16:23Znever https://clinicalinfo.hiv.gov/en/glossary/indication2024-10-24T03:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/latency-reversing-agents2024-07-29T16:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/male-circumcision2024-10-25T03:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/prep-navigation2024-10-25T03:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/label-use-02024-10-29T02:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/postattachment-inhibitor2024-07-06T02:09Zyearly https://clinicalinfo.hiv.gov/en/glossary/shock-and-kill-strategy2024-07-06T03:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/stigma2024-07-06T03:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/treatment-prevention-tasp2026-04-23T20:12Zmonthly https://clinicalinfo.hiv.gov/en/contact-us2025-09-29T18:53Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/coccidioidomycosis2025-09-30T20:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/talaromycosis2026-03-25T18:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/human-papillomavirus2025-12-22T19:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/prepregnancy-counseling-and-care2025-06-12T17:48Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/prepregnancy-counseling-childbearing-age-reproductive-options-partners2026-04-01T19:43Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/appendix-b-safety-and-toxicity-individual2024-01-16T16:07Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/non-nucleoside-reverse-transcriptase-inhibitors2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/tables2022-12-08T20:12Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/significant-drug-interactions2026-03-25T18:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/guidelines-panel-members2025-11-14T17:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/archived-drugs2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-amprenavir-agenerase2025-12-03T18:03Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cytomegalovirus2026-03-25T16:21Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/limitations-treatment-safety-and2020-11-26T19:17Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adherence-continuum-care2026-05-27T14:24Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/considerations-antiretroviral-use2024-09-12T17:31Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-tuberculosis-hiv2025-12-02T17:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/appendix-c-key-acronyms2025-04-09T15:40Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-name-abbreviations2025-12-01T23:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/prepregnancy-counseling-childbearing-age2025-06-12T18:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-indinavir-crixivan2025-12-03T18:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/appendix-pediatric-antiretroviral-drug-information2024-06-27T15:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/pharmacokinetic-enhancers2024-06-25T14:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/ritonavir2025-12-03T17:31Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/appendix-b-acronyms2024-06-27T15:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/laboratory-testing2020-11-26T19:17Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/management-people-hiv-and2024-09-12T16:56Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/optimizing-antiretroviral-therapy2026-05-27T14:28Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/integrase-inhibitors2024-01-24T23:04Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/antiretroviral-therapy-cost-considerations2026-05-27T14:26Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/management-medication-toxicity-or-intolerance2024-06-27T15:44Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/hematologic-effects2025-12-03T16:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/non-nucleoside-analogue-reverse-transcriptase2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/nevirapine2025-12-03T17:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/archived-drugs2024-06-25T14:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/saquinavir2025-12-03T17:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/entry-and-fusion-inhibitors2024-06-25T14:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/management-children-receiving-antiretroviral2024-06-27T15:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/hepatitis-b-virus-infection2026-04-13T22:47Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-born-people-hiv-infection2025-06-13T14:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-utero-intrapartum-breastfeeding-hiv-exposure2025-12-03T17:51Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-fosamprenavir-lexiva2025-12-03T18:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/general-terms2025-12-03T17:40Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/introduction2025-09-30T20:10Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/suboptimal-cd4-cell-recovery2026-02-06T15:40Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-c-virus-hiv2026-05-27T14:27Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-raltegravir-isentress2026-03-31T16:41Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/nucleoside-and-nucleotide-analogue-reverse2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-drug-interactions2020-11-26T19:17Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-protease-inhibitors2026-02-24T16:52Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-resistance-testing2026-02-05T21:41Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-diagnosis-hiv-infection-children2025-12-03T17:51Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/introduction2026-01-22T19:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hla-b-5701-screening2025-12-02T17:02Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/introduction2025-11-14T20:47Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-saquinavir-invirase2025-12-03T18:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-insti2025-12-01T23:59Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/bacterial-enteric2026-03-25T15:59Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/discontinuation-or-interruption-antiretroviral-therapy2025-12-02T17:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cryptosporidiosis2026-03-25T16:15Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cystoisosporiasis2026-03-25T16:17Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/fixed-dose-combinations2024-06-25T14:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-etravirine-intelence2026-03-31T16:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/nucleoside-and-nucleotide-analogue-reverse2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/zidovudine2025-12-03T17:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/figures2022-10-05T17:12Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-nrti2025-12-02T00:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/toxoplasmosis2026-03-25T18:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/pharmacoenhancers2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-pharmacoenhancers-ritonavir-norvir2026-03-31T20:11Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/maternal-hiv-testing-identification-exposure2025-11-28T15:27Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-overview2025-12-03T18:03Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/indinavir2025-12-03T17:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/tests-initial-assessment-follow-up2026-02-24T18:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations2024-09-12T17:01Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-substance-use-disorders2026-05-27T14:28Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/tables2022-10-05T17:10Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-5-significant-drug2025-12-02T20:12Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/plasma-hiv-1-rna-cd4-monitoring2025-12-02T17:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/overview2024-07-01T18:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-long-term-follow-up-exposed-arv-drugs2026-03-31T14:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/financial-disclosure2026-03-31T14:10Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/protease-inhibitors2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-protease-inhibitors-lopinavir-ritonavir-kaletra2026-04-02T18:31Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-protease-inhibitors-darunavir-prezista2026-03-31T16:37Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/antepartum-care-initial-evaluation-monitoring-hiv-assessments-during-pregnancy2026-03-31T14:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/arv-counseling-guide2026-04-01T16:21Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/hepatitis-c-virus-infection2026-01-28T16:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/intrapartum-care2026-04-01T16:09Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-pharmacoenhancers-cobicistat-tybost2026-03-31T16:41Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/ibalizumab2025-12-03T17:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/insulin-resistance-asymptomatic-hyperglycemia-diabetes-mellitus2025-12-03T16:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/prepregnancy-counseling-care-overview2026-03-30T19:56Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/integrase-inhibitors2024-06-25T14:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/pneumocycstis-jirovecii-pneumonia2025-12-22T19:46Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/efavirenz2025-12-03T17:17Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/cns-toxicity2025-12-03T16:23Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/nelfinavir2025-12-03T17:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/bartonellosis2026-03-25T16:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/treatment-hiv-associated2026-05-27T15:05Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-dolutegravir-tivicay2026-03-31T16:40Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/specific-considerations-antiretroviral-therapy-use-adolescents-hiv2025-11-18T20:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lactic-acidosis2025-12-03T16:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lamivudine2025-12-03T17:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/protease-inhibitors-pis2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/atazanavir2025-12-03T17:21Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-tipranavir-aptivus2025-12-03T18:06Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-hiv-2-infection2026-01-22T19:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendices2022-10-05T17:11Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-important-considerations2025-12-02T19:46Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/isosporiasis2025-09-30T20:18Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-emtricitabine-emtriva2026-03-31T16:31Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal-hiv-clinical-guidelines/entry-and-attachment-inhibitors2020-11-26T19:30Znever https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/dolutegravir2025-12-03T17:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/virologic-failure2026-02-24T16:49Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lopinavirritonavir2025-12-03T17:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-doravirine-pifeltro2026-03-31T16:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adverse-effects-antiretroviral-medications2026-05-27T15:18Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/nephrotoxic-effects2025-12-03T16:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-enfuvritide-fuzeon2025-12-03T18:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/stavudine2025-12-03T17:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/malaria2026-05-27T15:12Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/candida-infections2026-02-06T17:56Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/candidiasis2026-03-25T16:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/varicella-zoster2026-03-25T18:15Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/panel-roster2026-04-02T18:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/postpartum-management-follow-up2026-04-02T18:18Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/community-acquired2026-05-27T15:09Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/co-receptor-tropism-assays2025-12-02T17:02Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/review-clinical-trials-arv-interventions-prevent-hiv-transmission2025-12-02T23:22Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-b-virus-hiv2025-12-02T17:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/overview-02024-07-01T16:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-hiv-and-older-person2026-05-27T14:28Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/rash-and-hypersensitivity-reactions2025-12-03T16:27Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-overview2025-12-02T00:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-bictegravir2026-03-31T16:39Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/hepatitis-c-virus2026-03-25T16:36Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/immunizations-for-preventable-diseases2025-09-30T20:11Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-stavudine-zerit2025-12-03T18:06Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-efavirenz-sustiva2026-03-31T16:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-panel-roster2026-04-23T18:23Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/elvitegravir2025-12-03T17:30Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cryptosporidiosis2025-09-30T20:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/raltegravir2025-12-03T17:30Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/histoplasmosis2025-09-30T20:17Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/chagas-disease2026-03-25T16:06Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-ccr5-antagonist2025-12-01T23:44Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-ibalizumab-uiyk-trogarzo2026-03-31T16:38Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/darunavir2025-12-03T17:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/management-infants-utero-intrapartum-breastfeeding-hiv-exposure2025-07-23T17:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human2026-03-25T16:40Zyearly https://clinicalinfo.hiv.gov/en/guidelines/guidance-hiv-disasters/appendix-antiretroviral-medications-switched-temporarily2026-05-29T18:42Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-maraviroc-selzentry2026-03-31T16:38Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/disseminated2026-05-27T15:11Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/mycobacterium-avium-complex2026-04-23T20:32Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/fosamprenavir2025-12-03T17:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/varicella-zoster-virus2026-04-23T18:22Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/preventing-transmission-infant-feeding2025-06-12T19:08Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-financial-disclosures2026-04-23T18:25Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/guidance-hiv-disasters/appendix-sample-short-intake-form2026-02-23T20:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-nevirapine-viramune2026-03-31T16:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/indications-discontinuing-and2026-05-27T15:04Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-early-acute-recent-hiv-infection2026-05-27T14:27Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-pregnancy-registry2024-05-07T20:59Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-arv/what-start2024-06-27T15:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-rilpivirine-edurant2026-03-31T16:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/lipodystrophies-and-weight-gain2025-12-03T16:26Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/financial-disclosure2025-09-30T13:47Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-tenofovir-alafenamide-vemlidy2026-03-31T16:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/syphilis2026-05-27T15:13Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/doravirine2025-12-03T17:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/drug-abbreviations2025-12-03T17:39Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/pneumocystis2026-05-27T15:21Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/bictegravir2025-12-03T17:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/financial-disclosure2026-05-28T20:33Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/hepatic-events2025-12-03T16:24Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/when-initiate-therapy-antiretroviral-naive-children2025-11-14T21:42Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-initial-postnatal-neonate-exposed-hiv2025-12-03T17:51Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/general-terms2026-03-30T15:16Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new2026-05-27T15:53Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/histoplasmosis2026-03-25T16:38Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/maraviroc2025-12-03T17:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-zalcitabine-hivid2025-12-03T18:06Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/appendix-d-supplemental-information2024-07-01T18:59Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-list2026-03-25T19:13Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/adherence-antiretroviral-therapy-children-and-adolescents-living-hiv2025-11-17T20:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/guidance-hiv-disasters/non-specialized-providers2026-05-29T18:43Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cytomegalovirus2025-09-30T20:53Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/abacavir2025-12-03T16:30Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/appendix-a-acronyms2024-01-16T17:21Znever https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-elvitegravir2026-03-31T16:40Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/microsporidiosis2026-03-25T17:50Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/didanosine2025-12-03T17:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/secondary-prophylaxis2026-04-23T18:30Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/regimens-not-recommended-initial-therapy-antiretroviral-naive-children2025-12-03T16:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cryptococcosis2026-03-25T16:10Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/diagnosis-hiv-infection-infants-and-children2025-11-14T20:54Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/whats-new2025-11-17T14:02Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/coccidioidomycosis2026-03-25T16:08Zyearly https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/what-start-initial-combination-regimens-antiretroviral-naive-12022-10-04T17:20Znever https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/prophylaxis-prevent-first-episode2026-05-27T15:23Zweekly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/tenofovir-df2025-12-03T17:12Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/progressive2026-03-25T18:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/overview-12025-12-03T16:22Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/maternal-hiv-testing-and-identification-perinatal-hiv-exposure2025-11-25T20:39Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/treatment-goals2026-01-22T19:11Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/syphilis2025-09-30T20:22Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/giardiasis2025-09-30T20:55Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/clinical-and-laboratory-monitoring-pediatric-hiv-infection2025-11-14T20:58Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/appendix-a-table-2-antiretroviral-fixed-dose-combination-tablets-and-copackaged-formulations2025-12-03T17:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/herpes-simplex-virus2025-09-30T20:17Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/leishmaniasis2026-03-25T19:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/mycobacterium-tuberculosis2025-09-30T20:21Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-lamivudine-epivir2026-03-31T16:32Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/appendix-table-1-antiretrovirals-available-fixed2025-12-03T17:31Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human-herpesvirus2026-03-25T16:38Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/dosing-recommendations-drugs-used2026-03-25T18:37Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/primary-prophylaxis-full2026-04-23T18:25Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/regimens-recommended-initial-therapy-antiretroviral-naive-children2025-12-03T16:17Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/emtricitabine2025-12-03T17:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/mycobacterium2026-03-25T17:54Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/panel-roster2026-05-28T21:37Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-adolescents-young-adults2026-05-27T14:25Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-3-treatment2026-04-23T18:34Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/antiretroviral-treatment-interruption-children-hiv2025-12-03T16:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/introduction2026-03-31T14:12Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/introduction2026-03-25T16:00Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/initiation-antiretroviral-therapy2025-11-21T21:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/herpes-simplex2026-03-25T16:36Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/cobicistat2025-12-03T17:30Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/enfuvirtide2025-12-03T17:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cryptococcosis2025-09-30T20:14Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new2026-04-10T17:50Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-zidovudine-retrovir2026-03-31T16:34Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/osteopenia-and-osteoporosis2025-12-03T16:27Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/antepartum-care-arv-drug-resistance-testing2026-03-31T14:15Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-tenofovir-disoproxil-fumarate-viread2026-03-31T16:33Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/recognizing-and-managing-antiretroviral-treatment-failure2025-12-03T16:29Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/malaria2025-09-30T20:19Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new2026-05-27T14:55Zweekly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/immunizations2026-05-27T15:11Zweekly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-delavirdine-rescriptor2025-12-03T18:03Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/etravirine2025-12-03T17:18Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/gastrointestinal-effects2025-12-03T16:23Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-protease-inhibitors-atazanavir-reyataz2026-03-31T16:36Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-nelfinavir-viracept2025-12-03T18:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-drug-use-pregnant-overview2026-03-31T14:38Zyearly https://clinicalinfo.hiv.gov/en/guidelines/guidance-hiv-disasters/appendix-web-based-resources-treating-preventing2026-02-23T19:59Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/dyslipidemia2025-12-03T16:23Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-4-common-drugs-used2025-12-02T20:03Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/tenofovir-af2025-12-03T17:05Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/modifying-antiretroviral-regimens-children-sustained-virologic-suppression2025-12-03T16:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-abacavir-ziagen2026-03-31T16:31Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/rilpivirine2025-12-03T17:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/recommended-immunizations-schedule2025-12-02T20:01Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/tipranavir2025-12-03T17:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/whats-new2026-04-23T20:18Zmonthly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/baseline-evaluation2026-02-04T21:25Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-between-nnrtis-pis2025-12-01T23:39Zyearly https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/overview-22025-12-03T16:28Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-between-instis-nnrtis-pis2025-12-01T23:39Zyearly https://clinicalinfo.hiv.gov/en/guidelines/perinatal/archived-drugs-didanosine-videx2025-12-03T18:04Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/toxoplasmosis2025-12-22T19:22Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-women-hiv2025-12-10T20:53Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/arv-therapy-as-prevention2025-11-21T21:35Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/microsporidiosis2025-09-30T20:20Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/bacterial-infections2025-09-30T20:48Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/common-or-serious-adverse-reactions2026-03-25T19:11Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-nnrti2025-12-02T00:01Zyearly https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/hepatitis-b-virus2026-05-27T15:10Zweekly https://clinicalinfo.hiv.gov/en/glossary/primary-hiv-infection2024-10-24T02:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/aids-encephalopathy2024-08-09T18:50Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-encephalopathy2024-08-15T02:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-associated-dementia-had2024-10-24T03:02Zyearly https://clinicalinfo.hiv.gov/en/glossary/immunoglobulin2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/canker-sore2024-06-29T00:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/programmed-cell-death2024-06-29T00:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/attenuated2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/b-cell2024-08-13T03:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/burkitts-lymphoma2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/yeast-infection2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/c-c-chemokine-receptor-52024-08-09T19:00Zyearly https://clinicalinfo.hiv.gov/en/glossary/cysteine-cysteine-chemokine-receptor-52020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/cd4-cell2024-08-13T03:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/helper-t-cell2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/cellular-immunity2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/health-care-financing-administration2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/interventional-study2024-02-14T18:46Znever https://clinicalinfo.hiv.gov/en/glossary/desert-fever2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/desert-rheumatism2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/san-joaquin-valley-fever2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/valley-fever2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/contagious2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-viral-core2024-08-15T02:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/cryoablation2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/torulosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/crypto2024-07-02T02:41Zyearly https://clinicalinfo.hiv.gov/en/glossary/c-x-c-chemokine-receptor-42024-08-09T19:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/fusin2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/cmv-retinitis2024-08-13T03:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/data-monitoring-committee-dmc2024-08-15T02:05Zyearly https://clinicalinfo.hiv.gov/en/glossary/data-and-safety-monitoring-committee-dsmc2024-10-24T02:52Zyearly https://clinicalinfo.hiv.gov/en/glossary/diabetes-mellitus2024-07-02T02:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/division-aids2024-08-15T02:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/double-masked-study2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/resistance2024-07-02T03:02Zyearly https://clinicalinfo.hiv.gov/en/glossary/enzyme-immunoassay2024-07-02T03:08Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-viral-envelope2024-08-15T02:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/hhv-42024-08-15T02:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-herpesvirus-42020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/erythrocyte2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/red-blood-corpuscle2024-08-17T02:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/condyloma-acuminatum2024-07-02T03:17Zyearly https://clinicalinfo.hiv.gov/en/glossary/venereal-warts2024-07-02T03:18Zyearly https://clinicalinfo.hiv.gov/en/glossary/genitourinary-system2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/urogenital-system2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/urogenital-tract2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/genotypic-assay2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/clap2025-04-09T19:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/glycoprotein-1202024-10-29T02:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/viral-envelope-glycoprotein-1202024-10-29T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/glycoprotein-1602024-10-29T02:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/viral-envelope-glycoprotein-1602024-10-29T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/glycoprotein-412024-10-29T02:11Zyearly https://clinicalinfo.hiv.gov/en/glossary/viral-envelope-glycoprotein-412024-10-29T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/hct2024-10-29T13:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/hgb2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/human-herpesviruses2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hodgkin-disease2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/humoral-immune-response2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/autoimmune-thrombocytopenic-purpura2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/idiopathic-thrombocytopenic-purpura2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/immune-thrombocytopenic-purpura2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/antigen-antibody-complex2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/immunomodulators2024-07-03T02:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/immunomodulatory-therapy2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/exclusioninclusion-criteria2024-07-02T03:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/inclusionexclusion-criteria2024-07-02T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-subjects-protection-review-board2024-07-03T02:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/integrase-inhibitor2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/immune-serum-globulin2024-07-03T02:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/karnofsky-score2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/common-logarithm2024-07-03T03:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/log2024-07-03T03:12Zyearly https://clinicalinfo.hiv.gov/en/glossary/logarithm2024-07-03T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/lymphocytic-interstitial-pneumonitis2024-07-03T21:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/lymphoid-interstitial-pneumonia2024-07-03T21:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/histiocyte2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/chronic-maintenance-therapy2024-07-03T21:34Zyearly https://clinicalinfo.hiv.gov/en/glossary/secondary-prophylaxis2024-07-03T21:34Zyearly https://clinicalinfo.hiv.gov/en/glossary/microbe2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/myodynia2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/myoneuroalgia2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/bone-marrow-suppression2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/national-prevention-information-network2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/non-nucleoside-analogue-reverse-transcriptase-inhibitor2024-08-17T01:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/nucleic-acid-amplification-test2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/comfort-care2024-07-04T01:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/supportive-care2024-07-04T01:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/symptom-management2024-07-04T01:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/pap-test2024-07-04T01:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/papanicolaou-test2024-07-04T01:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/phenotypic-assay2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/pneumocystis-carinii-pneumonia2025-04-28T18:59Zyearly https://clinicalinfo.hiv.gov/en/glossary/pcp2024-08-17T02:02Zyearly https://clinicalinfo.hiv.gov/en/glossary/pneumocystis-pneumonia-pcp2024-11-25T02:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/pneumocystosis2024-07-06T02:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/multivalent-vaccine2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/proviral-dna2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/mantoux-tuberculin-skin-test2024-07-09T01:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/purified-protein-derivative-test2024-07-09T01:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/people-aids2025-04-28T18:52Zyearly https://clinicalinfo.hiv.gov/en/glossary/people-hivaids2025-04-28T18:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/resistance-assay2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/care-act2024-08-13T03:37Zyearly https://clinicalinfo.hiv.gov/en/glossary/rescue-therapy2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/viral-set-point2024-10-29T03:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/sexually-transmitted-infection-sti2024-07-02T00:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/lumbar-puncture2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/sputum-culture2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/best-practice2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/standard-medical-care2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/standard-therapy2024-08-17T02:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/t-cell2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/tanner-staging2024-07-06T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-therapeutic-vaccine2024-08-15T02:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-toxicity2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/immunization2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/inoculation2024-07-09T01:40Zyearly https://clinicalinfo.hiv.gov/en/glossary/herpes-zoster2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/human-herpesvirus-32020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/virucide2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/leukocyte2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/antenatal2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/synergism2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/synergy2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/dress2024-08-15T02:03Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-hypersensitivity-syndrome2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/drug-reaction-eosinophilia-and-systemic-symptoms2025-04-28T18:27Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-opposition2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/bone-density-test2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/fatty-liver2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/immune-reconstitution-syndrome2024-07-03T02:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/immune-restoration-disease2024-07-03T02:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/coronary-risk-profile2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hyperadiposity2024-07-03T03:06Zyearly https://clinicalinfo.hiv.gov/en/glossary/black-box-warning2024-06-29T01:14Zyearly https://clinicalinfo.hiv.gov/en/glossary/maternal-child-transmission2025-04-09T20:25Zyearly https://clinicalinfo.hiv.gov/en/glossary/mother-child-transmission-mtct2025-04-09T20:25Zyearly https://clinicalinfo.hiv.gov/en/glossary/vertical-transmission2025-04-09T20:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/drug-label2024-07-04T01:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/prescribing-information2024-07-04T01:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/prescription-drug-labeling2024-07-04T01:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/product-label2024-07-04T01:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-cell-count2024-08-13T03:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-t-lymphocyte-count2024-08-13T03:42Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-cell-percentage2024-08-13T03:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/cd4-t-lymphocyte-percentage2024-08-13T03:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/comorbid-condition2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/compassionate-use2024-10-24T02:56Zyearly https://clinicalinfo.hiv.gov/en/glossary/mixed-status-couple2024-01-17T21:22Znever https://clinicalinfo.hiv.gov/en/glossary/bid-02024-09-03T12:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/bid-12024-11-15T21:17Zyearly https://clinicalinfo.hiv.gov/en/glossary/endpoint2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/outcome-measure2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/peak-concentration2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/trough-concentration2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/trough-level2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/buffalo-hump2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/sham2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/sugar-pill2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-preventive-vaccine2024-10-25T03:33Zyearly https://clinicalinfo.hiv.gov/en/glossary/qd-02024-10-29T02:56Zyearly https://clinicalinfo.hiv.gov/en/glossary/qd-12024-10-29T02:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/qid-02024-10-29T02:58Zyearly https://clinicalinfo.hiv.gov/en/glossary/qid-12024-10-29T02:57Zyearly https://clinicalinfo.hiv.gov/en/glossary/hmg-coa-reductase-inhibitor2024-08-15T03:00Zyearly https://clinicalinfo.hiv.gov/en/glossary/lipid-lowering-agent2024-10-29T02:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/tid-02024-10-29T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/tid-12024-10-29T03:04Zyearly https://clinicalinfo.hiv.gov/en/glossary/rebound2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/intra-abdominal-fat2024-07-09T02:26Zyearly https://clinicalinfo.hiv.gov/en/glossary/visceral-fat2024-07-09T02:27Zyearly https://clinicalinfo.hiv.gov/en/glossary/t-tropic-virus2024-10-29T03:07Zyearly https://clinicalinfo.hiv.gov/en/glossary/combination-therapy2026-05-07T15:33Zmonthly https://clinicalinfo.hiv.gov/en/glossary/combined-antiretroviral-therapy-cart2026-05-07T15:34Zmonthly https://clinicalinfo.hiv.gov/en/glossary/highly-active-antiretroviral-therapy-haart2026-05-07T15:34Zmonthly https://clinicalinfo.hiv.gov/en/glossary/nuclear-magnetic-resonance2024-10-25T03:06Zyearly https://clinicalinfo.hiv.gov/en/glossary/clade2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/cd8-cell2024-08-13T03:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/cytotoxic-t-lymphocyte2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/killer-t-cell2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/horizontal-transmission2025-04-09T20:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-herpesvirus-82020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/nucleoside-analogue-reverse-transcriptase-inhibitor2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/nucleotide-analogue-reverse-transcriptase-inhibitor2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/drug-formulation2024-02-15T02:41Znever https://clinicalinfo.hiv.gov/en/glossary/insulin-resistance-syndrome2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/metabolic-syndrome-x2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/syndrome-x2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/experimental-drug2024-07-03T02:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/isosporiasis2024-07-02T02:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/adverse-drug-reaction2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/ccr5-inhibitor2024-08-13T03:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/chemoprophylaxis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/concentration2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/acute-inflammatory-demyelinating-polyneuropathy2024-07-02T03:23Zyearly https://clinicalinfo.hiv.gov/en/glossary/hypersensitivity-reaction2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/high-blood-pressure2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/reservoir2024-07-03T02:48Zyearly https://clinicalinfo.hiv.gov/en/glossary/replication-cycle2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-gingivitis2024-08-15T02:54Zyearly https://clinicalinfo.hiv.gov/en/glossary/red-band-gingivitis2024-08-19T14:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/mastocyte2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hiv-associated-adult-onset-nemaline-myopathy2024-08-15T02:49Zyearly https://clinicalinfo.hiv.gov/en/glossary/rod-body-disease2024-07-04T01:17Zyearly https://clinicalinfo.hiv.gov/en/glossary/prevention-mother-child-transmission-pmtct2025-04-09T20:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/primary-prevention2024-07-06T02:31Zyearly https://clinicalinfo.hiv.gov/en/glossary/primary-resistance2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/m-tropic-virus2024-10-29T02:35Zyearly https://clinicalinfo.hiv.gov/en/glossary/macrophage-tropic-virus2024-07-06T02:43Zyearly https://clinicalinfo.hiv.gov/en/glossary/surrogate-marker2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/t-cell-depletion2024-08-12T16:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/regimen2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/transcription-and-translation2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/virologic-control2026-05-07T15:36Zmonthly https://clinicalinfo.hiv.gov/en/glossary/tropism2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/drug-holiday2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/secondary-resistance2024-06-28T21:32Zyearly https://clinicalinfo.hiv.gov/en/glossary/asymptomatic-hiv-infection2024-06-29T02:44Zyearly https://clinicalinfo.hiv.gov/en/glossary/clinical-latency2024-06-29T02:45Zyearly https://clinicalinfo.hiv.gov/en/glossary/c-section2024-08-13T03:30Zyearly https://clinicalinfo.hiv.gov/en/glossary/cytochrome-p450-3a42020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/pink-eye2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/red-eye2024-08-12T15:27Zyearly https://clinicalinfo.hiv.gov/en/glossary/blood-thinner2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/brain-attack2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hla-b5701-testing2024-10-29T02:24Zyearly https://clinicalinfo.hiv.gov/en/glossary/hives2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/memory-cell2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/bronchopneumonia2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/regulatory-t-cell2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/suppressor-t-cell2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/suppressor-t-lymphocyte2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/albuminuria2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/urine-albumin2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/penicillium-marneffei-infection2025-04-28T19:55Zyearly https://clinicalinfo.hiv.gov/en/glossary/penicilliosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/talaromycosis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/american-trypanosomiasis2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/treatment-simplification2024-08-17T03:13Zyearly https://clinicalinfo.hiv.gov/en/glossary/artificial-insemination2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/excipient-hyperbilirubinemia2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/urine-analysis2024-07-09T01:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/urine-test2024-07-09T01:38Zyearly https://clinicalinfo.hiv.gov/en/glossary/gamma-glutamyl-transferase2024-08-15T02:35Zyearly https://clinicalinfo.hiv.gov/en/glossary/serum-glutamic-oxaloacetic-transaminase2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/alanine-transaminase2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/serum-glutamate-pyruvate-transaminase-sgpt2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/hla-complex2024-08-15T02:59Zyearly https://clinicalinfo.hiv.gov/en/glossary/human-leukocyte-antigen-system2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/blood-sugar2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/sugar2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/seminal-fluid2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/prophylactic2024-07-02T02:39Zyearly https://clinicalinfo.hiv.gov/en/glossary/single-masked-study2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/child-pugh-score2024-08-13T03:53Zyearly https://clinicalinfo.hiv.gov/en/glossary/dm-tropic-virus2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/attachment2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/cyp3a-inhibitors2024-08-13T03:46Zyearly https://clinicalinfo.hiv.gov/en/glossary/negative-test-result2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/positive-test-result2020-11-26T18:43Znever https://clinicalinfo.hiv.gov/en/glossary/coronary-artery-disease2024-07-02T02:37Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-care-continuum2024-08-15T02:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/hiv-treatment-cascade2024-08-15T02:47Zyearly https://clinicalinfo.hiv.gov/en/glossary/kick-and-kill-strategy2024-07-06T03:15Zyearly https://clinicalinfo.hiv.gov/en/glossary/kick-kill-strategy2024-07-06T03:16Zyearly https://clinicalinfo.hiv.gov/en/glossary/shock-kill-strategy2024-07-06T03:16Zyearly